Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Trial record 1 of 1 for:    E1412
Previous Study | Return to List | Next Study

Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2016 by National Cancer Institute (NCI)
Sponsor:
Information provided by (Responsible Party):
National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:
NCT01856192
First received: May 14, 2013
Last updated: December 1, 2016
Last verified: October 2016
  Purpose
This randomized phase II trial studies how well rituximab and combination chemotherapy with or without lenalidomide work in treating patients with newly diagnosed stage II-IV diffuse large B cell lymphoma. Monoclonal antibodies, such as rituximab, may interfere with the ability of cancer cells to grow and spread. Drugs used in chemotherapy, such as cyclophosphamide, doxorubicin hydrochloride, vincristine sulfate, and prednisone, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Lenalidomide may stimulate the immune system in different ways and stop cancer cells from growing. It is not yet known whether rituximab and combination chemotherapy are more effective when given with or without lenalidomide in treating patients with diffuse large B cell lymphoma.

Condition Intervention Phase
Stage II Diffuse Large B-Cell Lymphoma
Stage III Diffuse Large B-Cell Lymphoma
Stage IV Diffuse Large B-Cell Lymphoma
Drug: Cyclophosphamide
Drug: Doxorubicin Hydrochloride
Other: Laboratory Biomarker Analysis
Drug: Lenalidomide
Drug: Prednisone
Biological: Rituximab
Drug: Vincristine Sulfate
Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Randomized Phase II Open Label Study of Lenalidomide R-CHOP (R2CHOP) vs RCHOP (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone) in Patients With Newly Diagnosed Diffuse Large B Cell Lymphoma

Resource links provided by NLM:


Further study details as provided by National Cancer Institute (NCI):

Primary Outcome Measures:
  • PFS [ Time Frame: Time from randomization to the earliest of documented disease progression, new primaries of the same type or death without progression, assessed up to 10 years ] [ Designated as safety issue: No ]
    The primary analysis of PFS will be performed including all randomized eligible patients using a one-sided log-rank test stratified on IPI (2-3 vs. 4-5), age (< 60 years vs >= 60 years) and molecular subtype (germinal center B-cell type [GCB] vs. activated B-cell type [ABC]). Cox proportional hazards models will be used to assess possible effects of baseline clinical and biological characteristics on outcome, including age, gender, disease stage, and IPI. Treatment and covariate interactions will also be examined.


Secondary Outcome Measures:
  • CR rate based on PET-CT scan [ Time Frame: Up to 10 years ] [ Designated as safety issue: No ]
    The comparison of CR between two arms will be performed with CMH test, stratified on IPI (2-3 vs 4-5), age (< 60 yrs vs >= 60 yrs) and molecular subtype (GCB vs. ABC). Exploratory logistic regression will be used to assess possible effects of baseline clinical and biological characteristics on outcome, including age, gender, disease stage, and IPI. Treatment and covariate interactions will also be examined.

  • OS [ Time Frame: Time from randomization until death due to any cause, assessed up to 10 years ] [ Designated as safety issue: No ]
    The method of Kaplan and Meier will be used to estimate OS, and stratified log-rank test will be used to compare OS between two arms.

  • Overall RR based on PET-CT scan [ Time Frame: Up to 10 years ] [ Designated as safety issue: No ]
    The comparison of RR between two arms will be performed with Cochran-Mantel-Haenszel (CMH) test, stratified on IPI (2-3 vs 4-5), age (< 60 yrs vs >= 60 yrs) and molecular subtype (GCB vs. ABC). Exploratory logistic regression will be used to assess possible effects of baseline clinical and biological characteristics on outcome, including age, gender, disease stage, and IPI. Treatment and covariate interactions will also be examined.


Other Outcome Measures:
  • Impact of DLBCL molecular subtype on outcome [ Time Frame: Up to 10 years ] [ Designated as safety issue: No ]
    Analysis will be based on classification by gene expression profile from paraffin-embedded tissue. A stratified log-rank test and Cochran-Mantel-Haenszel test will be used to compare PFS and RR between two molecular subtypes, respectively. Other secondary outcomes, including overall RR and OS will be compared using similar methods.

  • Interim PET scan [ Time Frame: Up to 10 years ] [ Designated as safety issue: No ]
    Will evaluate the relation between interim PET scan and PFS.


Estimated Enrollment: 345
Study Start Date: August 2013
Estimated Primary Completion Date: January 2018 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Arm A (rituximab, combination chemotherapy, lenalidomide)
Patients receive rituximab IV, cyclophosphamide IV, doxorubicin hydrochloride IV, and vincristine sulfate IV on day 1; prednisone PO on days 1-5; and lenalidomide PO on days 1-10. Treatment repeats every 21 days for 6 courses in the absence of disease progression or unacceptable toxicity.
Drug: Cyclophosphamide
Given IV
Other Names:
  • (-)-Cyclophosphamide
  • 2H-1,3,2-Oxazaphosphorine, 2-[bis(2-chloroethyl)amino]tetrahydro-, 2-oxide, monohydrate
  • Carloxan
  • Ciclofosfamida
  • Ciclofosfamide
  • Cicloxal
  • Clafen
  • Claphene
  • CP monohydrate
  • CTX
  • CYCLO-cell
  • Cycloblastin
  • Cycloblastine
  • Cyclophospham
  • Cyclophosphamid monohydrate
  • Cyclophosphamidum
  • Cyclophosphan
  • Cyclophosphane
  • Cyclophosphanum
  • Cyclostin
  • Cyclostine
  • Cytophosphan
  • Cytophosphane
  • Cytoxan
  • Fosfaseron
  • Genoxal
  • Genuxal
  • Ledoxina
  • Mitoxan
  • Neosar
  • Revimmune
  • Syklofosfamid
  • WR- 138719
Drug: Doxorubicin Hydrochloride
Given IV
Other Names:
  • 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8, 9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S-cis)- (9CI)
  • ADM
  • Adriacin
  • Adriamycin
  • Adriamycin Hydrochloride
  • Adriamycin PFS
  • Adriamycin RDF
  • ADRIAMYCIN, HYDROCHLORIDE
  • Adriamycine
  • Adriblastina
  • Adriblastine
  • Adrimedac
  • Chloridrato de Doxorrubicina
  • DOX
  • DOXO-CELL
  • Doxolem
  • Doxorubicin.HCl
  • Doxorubin
  • Farmiblastina
  • FI 106
  • FI-106
  • hydroxydaunorubicin
  • Rubex
Other: Laboratory Biomarker Analysis
Correlative studies
Drug: Lenalidomide
Given PO
Other Names:
  • CC-5013
  • CC5013
  • CDC 501
  • Revlimid
Drug: Prednisone
Given PO
Other Names:
  • .delta.1-Cortisone
  • 1, 2-Dehydrocortisone
  • Adasone
  • Cortancyl
  • Dacortin
  • DeCortin
  • Decortisyl
  • Decorton
  • Delta 1-Cortisone
  • Delta-Dome
  • Deltacortene
  • Deltacortisone
  • Deltadehydrocortisone
  • Deltasone
  • Deltison
  • Deltra
  • Econosone
  • Lisacort
  • Meprosona-F
  • Metacortandracin
  • Meticorten
  • Ofisolona
  • Orasone
  • Panafcort
  • Panasol-S
  • Paracort
  • PRED
  • Predicor
  • Predicorten
  • Prednicen-M
  • Prednicort
  • Prednidib
  • Prednilonga
  • Predniment
  • Prednisonum
  • Prednitone
  • Promifen
  • Servisone
  • SK-Prednisone
Biological: Rituximab
Given IV
Other Names:
  • ABP 798
  • BI 695500
  • C2B8 Monoclonal Antibody
  • Chimeric Anti-CD20 Antibody
  • CT-P10
  • IDEC-102
  • IDEC-C2B8
  • IDEC-C2B8 Monoclonal Antibody
  • MabThera
  • Monoclonal Antibody IDEC-C2B8
  • PF-05280586
  • Rituxan
  • Rituximab Biosimilar ABP 798
  • Rituximab Biosimilar BI 695500
  • Rituximab Biosimilar CT-P10
  • Rituximab Biosimilar PF-05280586
  • Rituximab Biosimilar RTXM83
  • Rituximab Biosimilar SAIT101
  • RTXM83
Drug: Vincristine Sulfate
Given IV
Other Names:
  • Kyocristine
  • Leurocristine Sulfate
  • Leurocristine, sulfate
  • Oncovin
  • Vincasar
  • Vincosid
  • Vincrex
  • Vincristine, sulfate
Active Comparator: Arm B (rituximab, combination chemotherapy)
Patients receive rituximab, cyclophosphamide, doxorubicin hydrochloride, vincristine sulfate, and prednisone as in Arm A. Treatment repeats every 21 days for 6 courses in the absence of disease progression or unacceptable toxicity.
Drug: Cyclophosphamide
Given IV
Other Names:
  • (-)-Cyclophosphamide
  • 2H-1,3,2-Oxazaphosphorine, 2-[bis(2-chloroethyl)amino]tetrahydro-, 2-oxide, monohydrate
  • Carloxan
  • Ciclofosfamida
  • Ciclofosfamide
  • Cicloxal
  • Clafen
  • Claphene
  • CP monohydrate
  • CTX
  • CYCLO-cell
  • Cycloblastin
  • Cycloblastine
  • Cyclophospham
  • Cyclophosphamid monohydrate
  • Cyclophosphamidum
  • Cyclophosphan
  • Cyclophosphane
  • Cyclophosphanum
  • Cyclostin
  • Cyclostine
  • Cytophosphan
  • Cytophosphane
  • Cytoxan
  • Fosfaseron
  • Genoxal
  • Genuxal
  • Ledoxina
  • Mitoxan
  • Neosar
  • Revimmune
  • Syklofosfamid
  • WR- 138719
Drug: Doxorubicin Hydrochloride
Given IV
Other Names:
  • 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8, 9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S-cis)- (9CI)
  • ADM
  • Adriacin
  • Adriamycin
  • Adriamycin Hydrochloride
  • Adriamycin PFS
  • Adriamycin RDF
  • ADRIAMYCIN, HYDROCHLORIDE
  • Adriamycine
  • Adriblastina
  • Adriblastine
  • Adrimedac
  • Chloridrato de Doxorrubicina
  • DOX
  • DOXO-CELL
  • Doxolem
  • Doxorubicin.HCl
  • Doxorubin
  • Farmiblastina
  • FI 106
  • FI-106
  • hydroxydaunorubicin
  • Rubex
Other: Laboratory Biomarker Analysis
Correlative studies
Drug: Prednisone
Given PO
Other Names:
  • .delta.1-Cortisone
  • 1, 2-Dehydrocortisone
  • Adasone
  • Cortancyl
  • Dacortin
  • DeCortin
  • Decortisyl
  • Decorton
  • Delta 1-Cortisone
  • Delta-Dome
  • Deltacortene
  • Deltacortisone
  • Deltadehydrocortisone
  • Deltasone
  • Deltison
  • Deltra
  • Econosone
  • Lisacort
  • Meprosona-F
  • Metacortandracin
  • Meticorten
  • Ofisolona
  • Orasone
  • Panafcort
  • Panasol-S
  • Paracort
  • PRED
  • Predicor
  • Predicorten
  • Prednicen-M
  • Prednicort
  • Prednidib
  • Prednilonga
  • Predniment
  • Prednisonum
  • Prednitone
  • Promifen
  • Servisone
  • SK-Prednisone
Biological: Rituximab
Given IV
Other Names:
  • ABP 798
  • BI 695500
  • C2B8 Monoclonal Antibody
  • Chimeric Anti-CD20 Antibody
  • CT-P10
  • IDEC-102
  • IDEC-C2B8
  • IDEC-C2B8 Monoclonal Antibody
  • MabThera
  • Monoclonal Antibody IDEC-C2B8
  • PF-05280586
  • Rituxan
  • Rituximab Biosimilar ABP 798
  • Rituximab Biosimilar BI 695500
  • Rituximab Biosimilar CT-P10
  • Rituximab Biosimilar PF-05280586
  • Rituximab Biosimilar RTXM83
  • Rituximab Biosimilar SAIT101
  • RTXM83
Drug: Vincristine Sulfate
Given IV
Other Names:
  • Kyocristine
  • Leurocristine Sulfate
  • Leurocristine, sulfate
  • Oncovin
  • Vincasar
  • Vincosid
  • Vincrex
  • Vincristine, sulfate

Detailed Description:

PRIMARY OBJECTIVES:

I. Progression-free survival (PFS).

SECONDARY OBJECTIVES:

I. Response rate (RR). II. Complete remission (CR) rate as defined by positron emission tomography (PET)-computed tomography (CT) criteria.

III. Overall survival (OS).

TERTIARY OBJECTIVES:

I. Impact of diffuse large B cell lymphoma (DLBCL) molecular subtype on outcome.

II. Interim PET scan results in relation to treatment outcome.

OUTLINE: Patients are randomized to 1 of 2 treatment arms.

ARM A: Patients receive rituximab intravenously (IV), cyclophosphamide IV, doxorubicin hydrochloride IV, and vincristine sulfate IV on day 1; prednisone orally (PO) on days 1-5; and lenalidomide PO on days 1-10. Treatment repeats every 21 days for 6 courses in the absence of disease progression or unacceptable toxicity.

ARM B: Patients receive rituximab, cyclophosphamide, doxorubicin hydrochloride, vincristine sulfate, and prednisone as in Arm A. Treatment repeats every 21 days for 6 courses in the absence of disease progression or unacceptable toxicity.

After completion of study treatment, patients are followed up every 3 months for 2 years, every 6 months for 1 year, and then annually for up to 7 years.

  Eligibility

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • PRE-REGISTRATION (STEP 0)
  • Histologically confirmed DLBCL expressing CD20 antigen; patients with transformed lymphoma are excluded; in this regard, patients with composite lymphoma in the diagnostic tissue (concomitant DLBCL and follicular or other low-grade lymphoma component) are excluded; however, patients with DLBCL in primary diagnostic tissue but a bone marrow that shows low grade or indeterminate lymphoma are eligible; patients with known primary mediastinal large B-cell lymphoma (PMLBCL) are excluded; similarly, patients with known c-myc translocation (by fluorescence in situ hybridization) positive DLBCL are encouraged to participate in trials specifically designed for these patients; however patients with known c-myc DLBC positive are NOT excluded from this study; c-myc testing prior to study enrollment is NOT required
  • Stages II bulky disease (defined as mass size of more than 10 cm), stage III, or IV (Ann Arbor staging); patients with stage I and stage II non-bulky disease are excluded from this study
  • A paraffin-embedded tumor tissue specimen from the initial diagnostic biopsy has been located and ready to ship to the Mayo Clinic Lymphoma Laboratory following pre-registration; Note: exisional tumor biopsy is preferred; core needle biopsies will be considered adequate if there is enough tissue for the mandatory central pathology review immunohistochemistry and Genomics Education Partnership (GEP); submission of a tumor block is preferred, but if unavailable submit alternative materials
  • Eastern Cooperative Oncology Group (ECOG) performance status 0-2
  • Previously untreated and not receiving any other agent that would be considered as a treatment for the lymphoma; for subjects with severe systemic symptoms, compressive disease, or rapidly progressing symptomatic adenopathy, are allowed for lymphoma associated symptom treatment with up to 1 mg/kg/day prednisone, or equivalent, for a maximum of 7 days is permitted prior to beginning the treatment, at the discretion of the investigator; a washout period does not apply
  • No known central nervous system (CNS) lymphoma or cerebrospinal fluid involvement with malignant lymphoma cells; these patients are usually treated with CNS directed therapy; screening for cerebrospinal fluid (CSF)/CNS involvement is NOT required but can be performed per treating medical doctor (MD) discretion; intrathecal (IT) methotrexate or IT cytarabine prophylaxis in patients with negative CSF who are felt to be at high risk of CNS relapse is allowed per local MD discretion; this should be noted on the treatment form
  • Absence of history of myocardial infarction =< 6 months, or congestive heart failure requiring use of ongoing maintenance therapy for life-threatening ventricular arrhythmias
  • Absence of history of deep venous thrombosis/embolism, threatening thromboembolism or known thrombophilia; patients with a history of deep vein thrombosis(DVT)/pulmonary embolism (PE) or thrombophilia may participate if they are willing to be on full anticoagulation during the treatment if randomized to rituximab, cyclophosphamide, doxorubicin hydrochloride, vincristine sulfate, and prednisone (R2CHOP) arm A; full anticoagulation is defined as warfarin, factor X inhibitors, or low molecular weight heparin at therapeutic doses
  • Patient must be able and willing to receive anticoagulation therapy with aspirin 70-325 mg daily prophylaxis, low molecular weight heparin, factor X inhibitors or warfarin; patients unable or unwilling to take any prophylaxis are NOT eligible
  • Absence of history of acquired immune deficiency syndrome (AIDS)-related conditions (other than the presenting DLBCL) or post-transplant lymphoproliferative disorder (PTLD) in immunocompromised patients; patients with human immunodeficiency virus (HIV) on antiretroviral therapy other than zidovudine (AZT) and/or stavudine and without prior AIDS defining conditions and adequate CD4 count (> 400) are eligible
  • No other active malignancy requiring therapy such as radiation, chemotherapy, or immunotherapy; exceptions to this are as follows: localized non-melanotic skin cancer and any cancer that in the judgment of the investigator has been treated with curative intent and will not interfere with the study treatment plan and response assessment
  • No history of radiation therapy to >= 25% of the bone marrow for other diseases or history of anthracycline therapy
  • Patients must not be receiving erythroid stimulating agents (EPO: Procrit, Aranesp)
  • RANDOMIZATION (STEP 1)
  • Patient meets the eligibility criteria outlined above
  • Site has received notification from Mayo Clinic - Rochester Division of Hematopathology of the central confirmation of diagnosis and tissue adequacy for mandatory research studies
  • Patients must have measurable disease (at least 1 lesion of >= 1.5 cm in one diameter) as detected by computed tomography (CT) or the CT images of the positron emission tomography (PET)/CT
  • International Prognostic Index (IPI) of 2 or greater
  • Ejection fraction of >= 45% by either multi-gated acquisition (MUGA) scan or echocardiogram (ECHO)
  • Absence of co-morbid systemic illnesses or other severe concurrent disease which, in the judgment of the investigator, would make the patient inappropriate for entry into this study or interfere significantly with the proper assessment of safety and toxicity of the prescribed regimens, including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements
  • Absolute neutrophil count (ANC) >= 1500
  • Platelets (PLT) >= 100,000
  • Total bilirubin =< 1.5 x upper limit of normal (ULN) or if total bilirubin is > 1.5 x ULN, the direct bilirubin must be normal
  • Alkaline (Alk.) phosphatase =< 3 x ULN unless evidence of the direct liver involvement by lymphoma - then =< 5 x ULN
  • Aspartate aminotransferase (AST) =< 3 x ULN unless evidence of the direct liver involvement by lymphoma - then =< 5 x ULN
  • Creatinine =< 2 x ULN or creatinine clearance (CrCl) > 30 ml/min
  • Women must not be pregnant or breast-feeding
  • Females of childbearing potential (FCBP) must have a negative serum or urine pregnancy test with a sensitivity of at least 25 mIU/mL within 10-14 days prior to and again within 24 hours of starting lenalidomide and must either commit to continued abstinence from heterosexual intercourse or begin TWO acceptable methods of birth control, one highly effective method and one additional effective method AT THE SAME TIME, at least 28 days before she starts taking lenalidomide; FCBP must also agree to ongoing pregnancy testing; a female of childbearing potential is any woman, regardless of sexual orientation or whether they have undergone tubal ligation, who meets the following criteria: 1) has not undergone a hysterectomy or bilateral oophorectomy; or 2) has not been naturally postmenopausal for at least 24 consecutive months (i.e., has had menses at any time in the preceding 24 consecutive months)
  • Men must agree to use a latex condom during sexual contact with a FCBP even if they have had a successful vasectomy; all patients must be counseled at a minimum of every 28 days about pregnancy precautions and risks of fetal exposure
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01856192

  Hide Study Locations
Locations
United States, Alaska
Alaska Breast Care and Surgery LLC Recruiting
Anchorage, Alaska, United States, 99508
Contact: Keith S. Lanier    503-215-2614    CanRsrchStudies@providence.org   
Principal Investigator: Keith S. Lanier         
Alaska Women's Cancer Care Recruiting
Anchorage, Alaska, United States, 99508
Contact: Keith S. Lanier    503-215-2614    CanRsrchStudies@providence.org   
Principal Investigator: Keith S. Lanier         
Anchorage Oncology Centre Recruiting
Anchorage, Alaska, United States, 99508
Contact: Keith S. Lanier    503-215-2614    CanRsrchStudies@providence.org   
Principal Investigator: Keith S. Lanier         
Katmai Oncology Group Recruiting
Anchorage, Alaska, United States, 99508
Contact: Keith S. Lanier    503-215-2614    CanRsrchStudies@providence.org   
Principal Investigator: Keith S. Lanier         
Providence Alaska Medical Center Recruiting
Anchorage, Alaska, United States, 99508
Contact: Keith S. Lanier    503-215-2614    CanRsrchStudies@providence.org   
Principal Investigator: Keith S. Lanier         
United States, Arizona
Mayo Clinic in Arizona Recruiting
Scottsdale, Arizona, United States, 85259
Contact: Grzegorz S. Nowakowski    855-776-0015      
Principal Investigator: Grzegorz S. Nowakowski         
University of Arizona Cancer Center-North Campus Recruiting
Tucson, Arizona, United States, 85719
Contact: Daniel O. Persky    520-626-9008      
Principal Investigator: Daniel O. Persky         
The University of Arizona Medical Center-University Campus Recruiting
Tucson, Arizona, United States, 85724
Contact: Daniel O. Persky    520-626-9008      
Principal Investigator: Daniel O. Persky         
United States, Arkansas
Veteran's Administration Medical Center Recruiting
Little Rock, Arkansas, United States, 72205
Contact: Zhifu Xiang    501-686-8274      
Principal Investigator: Zhifu Xiang         
United States, California
Kaiser Permanente-Deer Valley Medical Center Recruiting
Antioch, California, United States, 94531
Contact: Tatjana Kolevska    626-564-3455      
Principal Investigator: Tatjana Kolevska         
Sutter Auburn Faith Hospital Recruiting
Auburn, California, United States, 95602
Contact: Jorge A. Garcia-Young    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Jorge A. Garcia-Young         
Kaiser Permanente-Baldwin Park Recruiting
Baldwin Park, California, United States, 91706
Contact: Han A. Koh    626-564-3455      
Principal Investigator: Han A. Koh         
Providence Saint Joseph Medical Center/Disney Family Cancer Center Recruiting
Burbank, California, United States, 91505
Contact: Keith S. Lanier    503-215-2614    CanRsrchStudies@providence.org   
Principal Investigator: Keith S. Lanier         
Kaiser Permanente-Irvine Recruiting
Irvine, California, United States, 92618
Contact: Han A. Koh    626-564-3455      
Principal Investigator: Han A. Koh         
Loma Linda University Medical Center Recruiting
Loma Linda, California, United States, 92354
Contact: Chien-Shing (. Chen    909-558-3375      
Principal Investigator: Chien-Shing (. Chen         
Memorial Medical Center Recruiting
Modesto, California, United States, 95355
Contact: Jorge A. Garcia-Young    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Jorge A. Garcia-Young         
Palo Alto Medical Foundation-Camino Division Recruiting
Mountain View, California, United States, 94040
Contact: Jorge A. Garcia-Young    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Jorge A. Garcia-Young         
Palo Alto Medical Foundation-Gynecologic Oncology Recruiting
Mountain View, California, United States, 94040
Contact: Jorge A. Garcia-Young    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Jorge A. Garcia-Young         
Kaiser Permanente-Oakland Recruiting
Oakland, California, United States, 94611
Contact: Tatjana Kolevska    626-564-3455      
Principal Investigator: Tatjana Kolevska         
UC Irvine Health/Chao Family Comprehensive Cancer Center Suspended
Orange, California, United States, 92868
Palo Alto Medical Foundation Health Care Recruiting
Palo Alto, California, United States, 94301
Contact: Jorge A. Garcia-Young    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Jorge A. Garcia-Young         
Stanford Cancer Institute Recruiting
Palo Alto, California, United States, 94304
Contact: Ranjana H. Advani    650-498-7061    clinicaltrials@med.stanford.edu   
Principal Investigator: Ranjana H. Advani         
Kaiser Permanente - Panorama City Recruiting
Panorama City, California, United States, 91402
Contact: Han A. Koh    626-564-3455      
Principal Investigator: Han A. Koh         
Kaiser Permanente-Richmond Recruiting
Richmond, California, United States, 94801
Contact: Tatjana Kolevska    626-564-3455      
Principal Investigator: Tatjana Kolevska         
Sutter General Hospital Recruiting
Sacramento, California, United States, 95816
Contact: Jorge A. Garcia-Young    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Jorge A. Garcia-Young         
Kaiser Permanente-South Sacramento Recruiting
Sacramento, California, United States, 95823
Contact: Tatjana Kolevska    626-564-3455      
Principal Investigator: Tatjana Kolevska         
Kaiser Permanente - Sacramento Recruiting
Sacramento, California, United States, 95825
Contact: Tatjana Kolevska    626-564-3455      
Principal Investigator: Tatjana Kolevska         
Kaiser Permanente-San Diego Mission Recruiting
San Diego, California, United States, 92108
Contact: Han A. Koh    626-564-3455      
Principal Investigator: Han A. Koh         
Kaiser Permanente-San Diego Zion Recruiting
San Diego, California, United States, 92120
Contact: Han A. Koh    626-564-3455      
Principal Investigator: Han A. Koh         
California Pacific Medical Center-Pacific Campus Recruiting
San Francisco, California, United States, 94115
Contact: Jorge A. Garcia-Young    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Jorge A. Garcia-Young         
Kaiser Permanente-San Francisco Recruiting
San Francisco, California, United States, 94115
Contact: Tatjana Kolevska    626-564-3455      
Principal Investigator: Tatjana Kolevska         
Kaiser Permanente-Santa Teresa-San Jose Recruiting
San Jose, California, United States, 95119
Contact: Tatjana Kolevska    626-564-3455      
Principal Investigator: Tatjana Kolevska         
Stanford Cancer Center South Bay Recruiting
San Jose, California, United States, 95124
Contact: Ranjana H. Advani    650-498-7061    clinicaltrials@med.stanford.edu   
Principal Investigator: Ranjana H. Advani         
Kaiser Permanente-San Marcos Recruiting
San Marcos, California, United States, 92069
Contact: Han A. Koh    626-564-3455      
Principal Investigator: Han A. Koh         
Kaiser Permanente-San Rafael Recruiting
San Rafael, California, United States, 94903
Contact: Tatjana Kolevska    626-564-3455      
Principal Investigator: Tatjana Kolevska         
Kaiser Permanente Medical Center - Santa Clara Recruiting
Santa Clara, California, United States, 95051
Contact: Tatjana Kolevska    626-564-3455      
Principal Investigator: Tatjana Kolevska         
Palo Alto Medical Foundation-Santa Cruz Recruiting
Santa Cruz, California, United States, 95065
Contact: Jorge A. Garcia-Young    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Jorge A. Garcia-Young         
Kaiser Permanente-Santa Rosa Recruiting
Santa Rosa, California, United States, 95403
Contact: Tatjana Kolevska    626-564-3455      
Principal Investigator: Tatjana Kolevska         
Sutter Pacific Medical Foundation Recruiting
Santa Rosa, California, United States, 95403
Contact: Jorge A. Garcia-Young    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Jorge A. Garcia-Young         
Kaiser Permanente-South San Francisco Recruiting
South San Francisco, California, United States, 94080
Contact: Tatjana Kolevska    626-564-3455      
Principal Investigator: Tatjana Kolevska         
Palo Alto Medical Foundation-Sunnyvale Recruiting
Sunnyvale, California, United States, 94086
Contact: Jorge A. Garcia-Young    415-209-2686    bernicl@sutterhealth.org   
Principal Investigator: Jorge A. Garcia-Young         
Kaiser Permanente-Walnut Creek Recruiting
Walnut Creek, California, United States, 94596
Contact: Tatjana Kolevska    626-564-3455      
Principal Investigator: Tatjana Kolevska         
Kaiser Permanente Recruiting
Woodland Hills, California, United States, 91367
Contact: Han A. Koh    626-564-3455      
Principal Investigator: Han A. Koh         
United States, Colorado
Rocky Mountain Cancer Centers-Aurora Recruiting
Aurora, Colorado, United States, 80012
Contact: Keren Sturtz    303-777-2663    kgeisen@co-cancerresearch.org   
Principal Investigator: Keren Sturtz         
The Medical Center of Aurora Recruiting
Aurora, Colorado, United States, 80012
Contact: Keren Sturtz    303-777-2663    kgeisen@co-cancerresearch.org   
Principal Investigator: Keren Sturtz         
Boulder Community Hospital Recruiting
Boulder, Colorado, United States, 80301
Contact: Keren Sturtz    303-777-2663    kgeisen@co-cancerresearch.org   
Principal Investigator: Keren Sturtz         
Penrose-Saint Francis Healthcare Recruiting
Colorado Springs, Colorado, United States, 80907
Contact: Keren Sturtz    303-777-2663    kgeisen@co-cancerresearch.org   
Principal Investigator: Keren Sturtz         
Rocky Mountain Cancer Centers-Penrose Suspended
Colorado Springs, Colorado, United States, 80907
Kaiser Permanente-Franklin Recruiting
Denver, Colorado, United States, 80205
Contact: Alexander Menter    303-614-1300      
Principal Investigator: Alexander Menter         
Porter Adventist Hospital Recruiting
Denver, Colorado, United States, 80210
Contact: Keren Sturtz    303-777-2663    kgeisen@co-cancerresearch.org   
Principal Investigator: Keren Sturtz         
Colorado Blood Cancer Institute Recruiting
Denver, Colorado, United States, 80218
Contact: Keren Sturtz    303-777-2663    kgeisen@co-cancerresearch.org   
Principal Investigator: Keren Sturtz         
Presbyterian - Saint Lukes Medical Center - Health One Recruiting
Denver, Colorado, United States, 80218
Contact: Keren Sturtz    303-777-2663    kgeisen@co-cancerresearch.org   
Principal Investigator: Keren Sturtz         
Rocky Mountain Cancer Centers-Midtown Recruiting
Denver, Colorado, United States, 80218
Contact: Keren Sturtz    303-777-2663    kgeisen@co-cancerresearch.org   
Principal Investigator: Keren Sturtz         
SCL Health Saint Joseph Hospital Recruiting
Denver, Colorado, United States, 80218
Contact: Keren Sturtz    303-777-2663    kgeisen@co-cancerresearch.org   
Principal Investigator: Keren Sturtz         
Rocky Mountain Cancer Centers-Rose Recruiting
Denver, Colorado, United States, 80220
Contact: Keren Sturtz    303-777-2663    kgeisen@co-cancerresearch.org   
Principal Investigator: Keren Sturtz         
Rose Medical Center Suspended
Denver, Colorado, United States, 80220
Colorado Cancer Research Program NCORP Recruiting
Denver, Colorado, United States, 80222
Contact: Keren Sturtz    888-785-6789      
Principal Investigator: Keren Sturtz         
Mercy Medical Center Recruiting
Durango, Colorado, United States, 81301
Contact: Keren Sturtz    303-777-2663    kgeisen@co-cancerresearch.org   
Principal Investigator: Keren Sturtz         
Comprehensive Cancer Care and Research Institute of Colorado LLC Recruiting
Englewood, Colorado, United States, 80113
Contact: Keren Sturtz    303-777-2663    kgeisen@co-cancerresearch.org   
Principal Investigator: Keren Sturtz         
Swedish Medical Center Recruiting
Englewood, Colorado, United States, 80113
Contact: Keren Sturtz    303-777-2663    kgeisen@co-cancerresearch.org   
Principal Investigator: Keren Sturtz         
Mountain Blue Cancer Care Center Suspended
Golden, Colorado, United States, 80401
North Colorado Medical Center Recruiting
Greeley, Colorado, United States, 80631
Contact: Keren Sturtz    303-777-2663    kgeisen@co-cancerresearch.org   
Principal Investigator: Keren Sturtz         
Rocky Mountain Cancer Centers-Greenwood Village Suspended
Greenwood Village, Colorado, United States, 80111
Kaiser Permanente-Rock Creek Recruiting
Lafayette, Colorado, United States, 80026
Contact: Alexander Menter    303-614-1300      
Principal Investigator: Alexander Menter         
Rocky Mountain Cancer Centers-Lakewood Suspended
Lakewood, Colorado, United States, 80228
Saint Anthony Hospital Recruiting
Lakewood, Colorado, United States, 80228
Contact: Mehmet S. Copur    800-998-2119      
Principal Investigator: Mehmet S. Copur         
Rocky Mountain Cancer Centers-Littleton Recruiting
Littleton, Colorado, United States, 80120
Contact: Keren Sturtz    303-777-2663    kgeisen@co-cancerresearch.org   
Principal Investigator: Keren Sturtz         
Littleton Adventist Hospital Recruiting
Littleton, Colorado, United States, 80122
Contact: Keren Sturtz    303-777-2663    kgeisen@co-cancerresearch.org   
Principal Investigator: Keren Sturtz         
Rocky Mountain Cancer Centers-Sky Ridge Recruiting
Lone Tree, Colorado, United States, 80124
Contact: Keren Sturtz    303-777-2663    kgeisen@co-cancerresearch.org   
Principal Investigator: Keren Sturtz         
Sky Ridge Medical Center Suspended
Lone Tree, Colorado, United States, 80124
Longmont United Hospital Recruiting
Longmont, Colorado, United States, 80501
Contact: Keren Sturtz    303-777-2663    kgeisen@co-cancerresearch.org   
Principal Investigator: Keren Sturtz         
Rocky Mountain Cancer Centers-Longmont Suspended
Longmont, Colorado, United States, 80501
McKee Medical Center Recruiting
Loveland, Colorado, United States, 80539
Contact: Keren Sturtz    303-777-2663    kgeisen@co-cancerresearch.org   
Principal Investigator: Keren Sturtz         
Parker Adventist Hospital Recruiting
Parker, Colorado, United States, 80138
Contact: Keren Sturtz    303-777-2663    kgeisen@co-cancerresearch.org   
Principal Investigator: Keren Sturtz         
Rocky Mountain Cancer Centers-Parker Suspended
Parker, Colorado, United States, 80138
Saint Mary Corwin Medical Center Recruiting
Pueblo, Colorado, United States, 81004
Contact: Keren Sturtz    303-777-2663    kgeisen@co-cancerresearch.org   
Principal Investigator: Keren Sturtz         
Rocky Mountain Cancer Centers-Thornton Suspended
Thornton, Colorado, United States, 80260
SCL Health Lutheran Medical Center Recruiting
Wheat Ridge, Colorado, United States, 80033
Contact: Keren Sturtz    303-777-2663    kgeisen@co-cancerresearch.org   
Principal Investigator: Keren Sturtz         
United States, Connecticut
Smilow Cancer Hospital Care Center at Saint Francis Recruiting
Hartford, Connecticut, United States, 06105
Contact: Adam M. Boruchov    860-714-4680      
Principal Investigator: Adam M. Boruchov         
The Hospital of Central Connecticut Suspended
New Britain, Connecticut, United States, 06050
Yale University Recruiting
New Haven, Connecticut, United States, 06520
Contact: Adam M. Boruchov    860-714-4680      
Principal Investigator: Adam M. Boruchov         
United States, Delaware
Bayhealth Medical Center at Kent General Active, not recruiting
Dover, Delaware, United States, 19901
Beebe Medical Center Recruiting
Lewes, Delaware, United States, 19958
Contact: Gregory A. Masters    302-733-6227      
Principal Investigator: Gregory A. Masters         
Delaware Clinical and Laboratory Physicians PA Recruiting
Newark, Delaware, United States, 19713
Contact: Gregory A. Masters    302-733-6227      
Principal Investigator: Gregory A. Masters         
Helen F Graham Cancer Center Recruiting
Newark, Delaware, United States, 19713
Contact: Gregory A. Masters    302-733-6227      
Principal Investigator: Gregory A. Masters         
Medical Oncology Hematology Consultants PA Recruiting
Newark, Delaware, United States, 19713
Contact: Gregory A. Masters    302-733-6227      
Principal Investigator: Gregory A. Masters         
Regional Hematology and Oncology PA Recruiting
Newark, Delaware, United States, 19713
Contact: Gregory A. Masters    302-733-6227      
Principal Investigator: Gregory A. Masters         
Christiana Care Health System-Christiana Hospital Recruiting
Newark, Delaware, United States, 19718
Contact: Gregory A. Masters    302-733-6227      
Principal Investigator: Gregory A. Masters         
Beebe Health Campus Recruiting
Rehoboth Beach, Delaware, United States, 19971
Contact: Gregory A. Masters    302-733-6227      
Principal Investigator: Gregory A. Masters         
Nanticoke Memorial Hospital Recruiting
Seaford, Delaware, United States, 19973
Contact: Gregory A. Masters    302-733-6227      
Principal Investigator: Gregory A. Masters         
United States, District of Columbia
Sibley Memorial Hospital Recruiting
Washington, District of Columbia, United States, 20016
Contact: Bruce R. Kressel    202-243-2373      
Principal Investigator: Bruce R. Kressel         
United States, Florida
The Watson Clinic Recruiting
Lakeland, Florida, United States, 33805
Contact: Galina Vugman    863-603-4720      
Principal Investigator: Galina Vugman         
UF Cancer Center at Orlando Health Recruiting
Orlando, Florida, United States, 32806
Contact: Julio J. Hajdenberg    321-841-7246    CancerClinicalTrials@orlandohealth.com   
Principal Investigator: Julio J. Hajdenberg         
United States, Georgia
Emory University/Winship Cancer Institute Recruiting
Atlanta, Georgia, United States, 30322
Contact: Jonathon B. Cohen    404-778-1868      
Principal Investigator: Jonathon B. Cohen         
Northside Hospital Recruiting
Atlanta, Georgia, United States, 30342
Contact: Lijo Simpson    404-501-3279      
Principal Investigator: Lijo Simpson         
Gwinnett Medical Center Recruiting
Lawrenceville, Georgia, United States, 30045
Contact: Aldemar Montero    678-312-2666      
Principal Investigator: Aldemar Montero         
Medical Center of Central Georgia Recruiting
Macon, Georgia, United States, 31201
Contact: Frederick M. Schnell    478-633-1226      
Principal Investigator: Frederick M. Schnell         
Lewis Cancer and Research Pavilion at Saint Joseph's/Candler Recruiting
Savannah, Georgia, United States, 31405
Contact: Grant C. Lewis    912-350-8568      
Principal Investigator: Grant C. Lewis         
United States, Hawaii
Hawaii Cancer Care Inc-POB II Recruiting
Honolulu, Hawaii, United States, 96813
Contact: Jeffrey L. Berenberg    808-524-6115      
Principal Investigator: Jeffrey L. Berenberg         
Straub Clinic and Hospital Recruiting
Honolulu, Hawaii, United States, 96813
Contact: Jeffrey L. Berenberg    808-524-6115      
Principal Investigator: Jeffrey L. Berenberg         
University of Hawaii Cancer Center Recruiting
Honolulu, Hawaii, United States, 96813
Contact: Jeffrey L. Berenberg    808-524-6115      
Principal Investigator: Jeffrey L. Berenberg         
Hawaii Oncology Inc-Kuakini Recruiting
Honolulu, Hawaii, United States, 96817
Contact: Jeffrey L. Berenberg    808-524-6115      
Principal Investigator: Jeffrey L. Berenberg         
The Cancer Center of Hawaii-Liliha Recruiting
Honolulu, Hawaii, United States, 96817
Contact: Jeffrey L. Berenberg    808-524-6115      
Principal Investigator: Jeffrey L. Berenberg         
Kaiser Permanente Moanalua Medical Center Recruiting
Honolulu, Hawaii, United States, 96819
Contact: Tatjana Kolevska    626-564-3455      
Principal Investigator: Tatjana Kolevska         
United States, Idaho
Saint Alphonsus Cancer Care Center-Boise Recruiting
Boise, Idaho, United States, 83706
Contact: Christopher M. Reynolds    734-712-4673      
Principal Investigator: Christopher M. Reynolds         
Saint Luke's Mountain States Tumor Institute Recruiting
Boise, Idaho, United States, 83712
Contact: Keith S. Lanier    503-215-2614    CanRsrchStudies@providence.org   
Principal Investigator: Keith S. Lanier         
Saint Luke's Mountain States Tumor Institute - Fruitland Recruiting
Fruitland, Idaho, United States, 83619
Contact: Keith S. Lanier    503-215-2614    CanRsrchStudies@providence.org   
Principal Investigator: Keith S. Lanier         
Saint Luke's Mountain States Tumor Institute - Meridian Recruiting
Meridian, Idaho, United States, 83642
Contact: Keith S. Lanier    503-215-2614    CanRsrchStudies@providence.org   
Principal Investigator: Keith S. Lanier         
Saint Luke's Mountain States Tumor Institute - Nampa Recruiting
Nampa, Idaho, United States, 83686
Contact: Keith S. Lanier    503-215-2614    CanRsrchStudies@providence.org   
Principal Investigator: Keith S. Lanier         
Kootenai Cancer Center Recruiting
Post Falls, Idaho, United States, 83854
Contact: Benjamin T. Marchello    800-648-6274      
Principal Investigator: Benjamin T. Marchello         
Saint Luke's Mountain States Tumor Institute-Twin Falls Recruiting
Twin Falls, Idaho, United States, 83301
Contact: Keith S. Lanier    503-215-2614    CanRsrchStudies@providence.org   
Principal Investigator: Keith S. Lanier         
United States, Illinois
Illinois CancerCare-Bloomington Recruiting
Bloomington, Illinois, United States, 61704
Contact: James L. Wade    217-876-4740    kcheek@dmhhs.org   
Principal Investigator: James L. Wade         
Illinois CancerCare-Canton Recruiting
Canton, Illinois, United States, 61520
Contact: James L. Wade    217-876-4740    kcheek@dmhhs.org   
Principal Investigator: James L. Wade         
Illinois CancerCare-Carthage Recruiting
Carthage, Illinois, United States, 62321
Contact: James L. Wade    217-876-4740    kcheek@dmhhs.org   
Principal Investigator: James L. Wade         
Northwestern University Recruiting
Chicago, Illinois, United States, 60611
Contact: Jason B. Kaplan    312-695-1301    cancer@northwestern.edu   
Principal Investigator: Jason B. Kaplan         
Weiss Memorial Hospital Recruiting
Chicago, Illinois, United States, 60640
Contact: Stuart A. Krauss    773-564-5044      
Principal Investigator: Stuart A. Krauss         
Presence Saint Joseph Hospital-Chicago Recruiting
Chicago, Illinois, United States, 60657
Contact: Ira A. Oliff       info@orchardhr.com   
Principal Investigator: Ira A. Oliff         
Carle on Vermilion Suspended
Danville, Illinois, United States, 61832
Cancer Care Center of Decatur Recruiting
Decatur, Illinois, United States, 62526
Contact: James L. Wade    217-876-4740    kcheek@dmhhs.org   
Principal Investigator: James L. Wade         
Decatur Memorial Hospital Recruiting
Decatur, Illinois, United States, 62526
Contact: James L. Wade    217-876-4740    kcheek@dmhhs.org   
Principal Investigator: James L. Wade         
Heartland Cancer Research NCORP Terminated
Decatur, Illinois, United States, 62526
Carle Physician Group-Effingham Suspended
Effingham, Illinois, United States, 62401
Crossroads Cancer Center Recruiting
Effingham, Illinois, United States, 62401
Contact: James L. Wade    217-876-4740    kcheek@dmhhs.org   
Principal Investigator: James L. Wade         
AMITA Health Alexian Brothers Medical Center Recruiting
Elk Grove Village, Illinois, United States, 60007
Contact: Bruce B. Bank    847-952-7164    fredianc@alexian.net   
Principal Investigator: Bruce B. Bank         
Illinois CancerCare-Eureka Recruiting
Eureka, Illinois, United States, 61530
Contact: James L. Wade    217-876-4740    kcheek@dmhhs.org   
Principal Investigator: James L. Wade         
Illinois CancerCare-Galesburg Cottage Plaza Office Recruiting
Galesburg, Illinois, United States, 61401
Contact: Nguyet A. Le-Lindqwister    800-793-2262      
Principal Investigator: Nguyet A. Le-Lindqwister         
Illinois CancerCare-Galesburg Recruiting
Galesburg, Illinois, United States, 61401
Contact: James L. Wade    217-876-4740    kcheek@dmhhs.org   
Principal Investigator: James L. Wade         
Northwestern Medicine Cancer Center Delnor Suspended
Geneva, Illinois, United States, 60134
Ingalls Memorial Hospital Recruiting
Harvey, Illinois, United States, 60426
Contact: Mark F. Kozloff    708-915-4673    clinicaltrials@ingalls.org   
Principal Investigator: Mark F. Kozloff         
Hinsdale Hematology Oncology Associates Incorporated Recruiting
Hinsdale, Illinois, United States, 60521
Contact: Elyse C. Schneiderman    630-654-1790    info@hhoaltd.com   
Principal Investigator: Elyse C. Schneiderman         
Joliet Oncology-Hematology Associates Limited Recruiting
Joliet, Illinois, United States, 60435
Contact: Jason J. Suh    815-730-3098    maureenc@jolietoncology.com   
Principal Investigator: Jason J. Suh         
Illinois CancerCare-Kewanee Clinic Recruiting
Kewanee, Illinois, United States, 61443
Contact: James L. Wade    217-876-4740    kcheek@dmhhs.org   
Principal Investigator: James L. Wade         
Illinois CancerCare-Macomb Recruiting
Macomb, Illinois, United States, 61455
Contact: James L. Wade    217-876-4740    kcheek@dmhhs.org   
Principal Investigator: James L. Wade         
Carle Physician Group-Mattoon/Charleston Suspended
Mattoon, Illinois, United States, 61938
Trinity Medical Center Suspended
Moline, Illinois, United States, 61265
Illinois CancerCare-Monmouth Terminated
Monmouth, Illinois, United States, 61462
Illinois Cancer Specialists-Niles Recruiting
Niles, Illinois, United States, 60714
Contact: Jason B. Kaplan    312-695-1301    cancer@northwestern.edu   
Principal Investigator: Jason B. Kaplan         
Illinois CancerCare-Ottawa Clinic Recruiting
Ottawa, Illinois, United States, 61350
Contact: James L. Wade    217-876-4740    kcheek@dmhhs.org   
Principal Investigator: James L. Wade         
Illinois CancerCare-Pekin Recruiting
Pekin, Illinois, United States, 61554
Contact: James L. Wade    217-876-4740    kcheek@dmhhs.org   
Principal Investigator: James L. Wade         
Illinois CancerCare-Peoria Recruiting
Peoria, Illinois, United States, 61615
Contact: James L. Wade    217-876-4740    kcheek@dmhhs.org   
Principal Investigator: James L. Wade         
Illinois CancerCare-Peru Recruiting
Peru, Illinois, United States, 61354
Contact: James L. Wade    217-876-4740    kcheek@dmhhs.org   
Principal Investigator: James L. Wade         
Illinois CancerCare-Princeton Recruiting
Princeton, Illinois, United States, 61356
Contact: James L. Wade    217-876-4740    kcheek@dmhhs.org   
Principal Investigator: James L. Wade         
West Suburban Medical Center Recruiting
River Forest, Illinois, United States, 60305
Contact: Isoken Koko    708-488-0882      
Principal Investigator: Isoken Koko         
Swedish American Hospital Withdrawn
Rockford, Illinois, United States, 61104
SwedishAmerican Regional Cancer Center/ACT Recruiting
Rockford, Illinois, United States, 61114
Contact: Harvey E. Einhorn    779-696-9400    cancercare@swedishamerican.org   
Principal Investigator: Harvey E. Einhorn         
Central Illinois Hematology Oncology Center Recruiting
Springfield, Illinois, United States, 62702
Contact: James L. Wade    217-876-4740    kcheek@dmhhs.org   
Principal Investigator: James L. Wade         
Southern Illinois University School of Medicine Recruiting
Springfield, Illinois, United States, 62702
Contact: James L. Wade    217-876-4740    kcheek@dmhhs.org   
Principal Investigator: James L. Wade         
Springfield Clinic Recruiting
Springfield, Illinois, United States, 62703
Contact: James L. Wade    217-876-4740    kcheek@dmhhs.org   
Principal Investigator: James L. Wade         
Memorial Medical Center Recruiting
Springfield, Illinois, United States, 62781
Contact: James L. Wade    217-876-4740    kcheek@dmhhs.org   
Principal Investigator: James L. Wade         
Cancer Care Specialists of Illinois-Swansea Recruiting
Swansea, Illinois, United States, 62226
Contact: James L. Wade    217-876-4740    kcheek@dmhhs.org   
Principal Investigator: James L. Wade         
Carle Cancer Center Suspended
Urbana, Illinois, United States, 61801
The Carle Foundation Hospital Suspended
Urbana, Illinois, United States, 61801
Northwestern Medicine Cancer Center Warrenville Recruiting
Warrenville, Illinois, United States, 60555
Contact: Robert A. Bayer    630-315-1918    Claudine.Gamster@CadenceHealth.org   
Principal Investigator: Robert A. Bayer         
United States, Indiana
Elkhart Clinic Terminated
Elkhart, Indiana, United States, 46514-2098
Michiana Hematology Oncology PC-Elkhart Terminated
Elkhart, Indiana, United States, 46514
Elkhart General Hospital Terminated
Elkhart, Indiana, United States, 46515
Indiana University/Melvin and Bren Simon Cancer Center Active, not recruiting
Indianapolis, Indiana, United States, 46202
IU Health Central Indiana Cancer Centers-East Active, not recruiting
Indianapolis, Indiana, United States, 46219
Community Howard Regional Health Terminated
Kokomo, Indiana, United States, 46904
IU Health La Porte Hospital Terminated
La Porte, Indiana, United States, 46350
IU Health Arnett Cancer Care Active, not recruiting
Lafayette, Indiana, United States, 47904
Premier Oncology Hematology Associates Active, not recruiting
Merrillville, Indiana, United States, 46410
Michiana Hematology Oncology PC-Mishawaka Suspended
Mishawaka, Indiana, United States, 46545
Saint Joseph Regional Medical Center-Mishawaka Suspended
Mishawaka, Indiana, United States, 46545
IU Health Ball Memorial Hospital Recruiting
Muncie, Indiana, United States, 47303
Contact: Michael J. Williamson    765-751-5850      
Principal Investigator: Michael J. Williamson         
Michiana Hematology Oncology PC-Plymouth Terminated
Plymouth, Indiana, United States, 46563
Reid Health Suspended
Richmond, Indiana, United States, 47374
Michiana Hematology Oncology PC-South Bend Suspended
South Bend, Indiana, United States, 46601
Northern Indiana Cancer Research Consortium Recruiting
South Bend, Indiana, United States, 46628
Contact: Jose A. Bufill    574-237-1328      
Principal Investigator: Jose A. Bufill         
Michiana Hematology Oncology PC-Westville Terminated
Westville, Indiana, United States, 46391
United States, Iowa
McFarland Clinic PC-William R Bliss Cancer Center Recruiting
Ames, Iowa, United States, 50010
Contact: Joseph J. Merchant    515-239-2621      
Principal Investigator: Joseph J. Merchant         
Oncology Associates at Mercy Medical Center Suspended
Cedar Rapids, Iowa, United States, 52403
Medical Oncology and Hematology Associates-West Des Moines Recruiting
Clive, Iowa, United States, 50325
Contact: Mehmet S. Copur    800-998-2119      
Principal Investigator: Mehmet S. Copur         
Mercy Cancer Center-West Lakes Recruiting
Clive, Iowa, United States, 50325
Contact: Mehmet S. Copur    800-998-2119      
Principal Investigator: Mehmet S. Copur         
Iowa-Wide Oncology Research Coalition NCORP Active, not recruiting
Des Moines, Iowa, United States, 50309
Medical Oncology and Hematology Associates-Des Moines Recruiting
Des Moines, Iowa, United States, 50309
Contact: Robert J. Behrens    515-282-2921      
Principal Investigator: Robert J. Behrens         
Medical Oncology and Hematology Associates-Laurel Recruiting
Des Moines, Iowa, United States, 50314
Contact: Mehmet S. Copur    800-998-2119      
Principal Investigator: Mehmet S. Copur         
Mercy Medical Center - Des Moines Recruiting
Des Moines, Iowa, United States, 50314
Contact: Mehmet S. Copur    800-998-2119      
Principal Investigator: Mehmet S. Copur         
Mercy Medical Center - North Iowa Recruiting
Mason City, Iowa, United States, 50401
Contact: Joginder (Joe) Singh    800-433-3883      
Principal Investigator: Joginder (Joe) Singh         
Ottumwa Regional Health Center Recruiting
Ottumwa, Iowa, United States, 52501
Contact: Praveen Vikas    641-469-4144      
Principal Investigator: Praveen Vikas         
Siouxland Regional Cancer Center Recruiting
Sioux City, Iowa, United States, 51101
Contact: Donald B. Wender    712-252-0088      
Principal Investigator: Donald B. Wender         
Covenant Medical Center Active, not recruiting
Waterloo, Iowa, United States, 50702
Mercy Medical Center-West Lakes Recruiting
West Des Moines, Iowa, United States, 50266
Contact: Mehmet S. Copur    800-998-2119      
Principal Investigator: Mehmet S. Copur         
United States, Kansas
Lawrence Memorial Hospital Recruiting
Lawrence, Kansas, United States, 66044
Contact: Shaker R. Dakhil    316-268-5374      
Principal Investigator: Shaker R. Dakhil         
Wesley Medical Center Recruiting
Wichita, Kansas, United States, 67214
Contact: Shaker R. Dakhil    316-268-5374      
Principal Investigator: Shaker R. Dakhil         
United States, Kentucky
Flaget Memorial Hospital Recruiting
Bardstown, Kentucky, United States, 40004
Contact: Mehmet S. Copur    800-998-2119      
Principal Investigator: Mehmet S. Copur         
Jewish Hospital Recruiting
Louisville, Kentucky, United States, 40202
Contact: Mehmet S. Copur    800-998-2119      
Principal Investigator: Mehmet S. Copur         
Jewish Hospital Medical Center Northeast Recruiting
Louisville, Kentucky, United States, 40245
Contact: Mehmet S. Copur    800-998-2119      
Principal Investigator: Mehmet S. Copur         
United States, Louisiana
Ochsner Health Center-Summa Recruiting
Baton Rouge, Louisiana, United States, 70809
Contact: Robert V. Emmons    888-562-4763      
Principal Investigator: Robert V. Emmons         
Ochsner Medical Center Kenner Suspended
Kenner, Louisiana, United States, 70065
University Health-Conway Recruiting
Monroe, Louisiana, United States, 71202
Contact: Richard P. Mansour    318-813-1412      
Principal Investigator: Richard P. Mansour         
Ochsner Medical Center Jefferson Recruiting
New Orleans, Louisiana, United States, 70121
Contact: Robert V. Emmons    888-562-4763      
Principal Investigator: Robert V. Emmons         
Louisiana State University Health Sciences Center Shreveport Recruiting
Shreveport, Louisiana, United States, 71103
Contact: Richard P. Mansour    318-813-1412      
Principal Investigator: Richard P. Mansour         
United States, Maine
Harold Alfond Center for Cancer Care Recruiting
Augusta, Maine, United States, 04330
Contact: Thomas H. Openshaw    800-987-3005      
Principal Investigator: Thomas H. Openshaw         
Eastern Maine Medical Center Recruiting
Bangor, Maine, United States, 04401
Contact: Thomas H. Openshaw    800-987-3005      
Principal Investigator: Thomas H. Openshaw         
Lafayette Family Cancer Center-EMMC Recruiting
Brewer, Maine, United States, 04412
Contact: Thomas H. Openshaw    800-987-3005      
Principal Investigator: Thomas H. Openshaw         
United States, Maryland
Greater Baltimore Medical Center Recruiting
Baltimore, Maryland, United States, 21204
Contact: Marshall A. Levine    443-849-3706      
Principal Investigator: Marshall A. Levine         
Johns Hopkins University/Sidney Kimmel Cancer Center Recruiting
Baltimore, Maryland, United States, 21287
Contact: Lode J. Swinnen    410-955-8804    jhcccro@jhmi.edu   
Principal Investigator: Lode J. Swinnen         
Union Hospital of Cecil County Active, not recruiting
Elkton, Maryland, United States, 21921
Peninsula Regional Medical Center Suspended
Salisbury, Maryland, United States, 21801
United States, Massachusetts
Tufts Medical Center Recruiting
Boston, Massachusetts, United States, 02111
Contact: Andrew M. Evens    617-636-5000    ContactUsCancerCenter@TuftsMedicalCenter.org   
Principal Investigator: Andrew M. Evens         
Boston Medical Center Suspended
Boston, Massachusetts, United States, 02118
Baystate Medical Center Recruiting
Springfield, Massachusetts, United States, 01199
Contact: Syed S. Ali    413-794-3565    tamara.wrenn@baystatehealth.org   
Principal Investigator: Syed S. Ali         
University of Massachusetts Medical School Recruiting
Worcester, Massachusetts, United States, 01655
Contact: Nahida Islam    508-856-3216    cancer.research@umassmed.edu   
Principal Investigator: Nahida Islam         
United States, Michigan
Saint Joseph Mercy Hospital Recruiting
Ann Arbor, Michigan, United States, 48106-0995
Contact: Christopher M. Reynolds    734-712-4673      
Principal Investigator: Christopher M. Reynolds         
University of Michigan Comprehensive Cancer Center Recruiting
Ann Arbor, Michigan, United States, 48109
Contact: Tycel J. Phillips    800-865-1125      
Principal Investigator: Tycel J. Phillips         
Bronson Battle Creek Suspended
Battle Creek, Michigan, United States, 49017
Beaumont Hospital-Dearborn Recruiting
Dearborn, Michigan, United States, 48124
Contact: Christopher M. Reynolds    734-712-4673      
Principal Investigator: Christopher M. Reynolds         
Wayne State University/Karmanos Cancer Institute Recruiting
Detroit, Michigan, United States, 48201
Contact: Jay Yang    313-576-9363      
Principal Investigator: Jay Yang         
Saint John Hospital and Medical Center Recruiting
Detroit, Michigan, United States, 48236
Contact: Christopher M. Reynolds    734-712-4673      
Principal Investigator: Christopher M. Reynolds         
Green Bay Oncology - Escanaba Recruiting
Escanaba, Michigan, United States, 49829
Contact: Brian L. Burnette    800-432-6049      
Principal Investigator: Brian L. Burnette         
Genesys Hurley Cancer Institute Recruiting
Flint, Michigan, United States, 48503
Contact: Christopher M. Reynolds    734-712-4673      
Principal Investigator: Christopher M. Reynolds         
Mercy Health Saint Mary's Suspended
Grand Rapids, Michigan, United States, 49503
Spectrum Health at Butterworth Campus Suspended
Grand Rapids, Michigan, United States, 49503
Green Bay Oncology - Iron Mountain Withdrawn
Iron Mountain, Michigan, United States, 49801
Allegiance Health Recruiting
Jackson, Michigan, United States, 49201
Contact: Christopher M. Reynolds    734-712-4673      
Principal Investigator: Christopher M. Reynolds         
West Michigan Cancer Center Suspended
Kalamazoo, Michigan, United States, 49007
Saint Mary Mercy Hospital Recruiting
Livonia, Michigan, United States, 48154
Contact: Christopher M. Reynolds    734-712-4673      
Principal Investigator: Christopher M. Reynolds         
Mercy Health Mercy Campus Suspended
Muskegon, Michigan, United States, 49444
Saint Joseph Mercy Oakland Recruiting
Pontiac, Michigan, United States, 48341
Contact: Christopher M. Reynolds    734-712-4673      
Principal Investigator: Christopher M. Reynolds         
Saint Joseph Mercy Port Huron Suspended
Port Huron, Michigan, United States, 48060
Spectrum Health Reed City Hospital Suspended
Reed City, Michigan, United States, 49677
Saint Mary's of Michigan Recruiting
Saginaw, Michigan, United States, 48601
Contact: Christopher M. Reynolds    734-712-4673      
Principal Investigator: Christopher M. Reynolds         
Lakeland Hospital Suspended
Saint Joseph, Michigan, United States, 49085
Marie Yeager Cancer Center Suspended
Saint Joseph, Michigan, United States, 49085
Munson Medical Center Suspended
Traverse City, Michigan, United States, 49684
Saint John Macomb-Oakland Hospital Recruiting
Warren, Michigan, United States, 48093
Contact: Christopher M. Reynolds    734-712-4673      
Principal Investigator: Christopher M. Reynolds         
United States, Minnesota
Sanford Clinic North-Bemidgi Recruiting
Bemidji, Minnesota, United States, 56601
Contact: Preston D. Steen    701-234-6161      
Principal Investigator: Preston D. Steen         
Fairview Ridges Hospital Recruiting
Burnsville, Minnesota, United States, 55337
Contact: Joseph W. Leach    952-993-1517    mmcorc@parknicollet.com   
Principal Investigator: Joseph W. Leach         
Mercy Hospital Recruiting
Coon Rapids, Minnesota, United States, 55433
Contact: Joseph W. Leach    952-993-1517    mmcorc@parknicollet.com   
Principal Investigator: Joseph W. Leach         
Essentia Health Cancer Center Recruiting
Duluth, Minnesota, United States, 55805
Contact: Bret E. Friday    888-203-7267      
Principal Investigator: Bret E. Friday         
Saint Luke's Hospital of Duluth Recruiting
Duluth, Minnesota, United States, 55805
Contact: Basem S. Goueli    218-249-7825    kdean@slhduluth.com   
Principal Investigator: Basem S. Goueli         
Fairview-Southdale Hospital Recruiting
Edina, Minnesota, United States, 55435
Contact: Joseph W. Leach    952-993-1517    mmcorc@parknicollet.com   
Principal Investigator: Joseph W. Leach         
Lake Region Healthcare Corporation-Cancer Care Recruiting
Fergus Falls, Minnesota, United States, 56537
Contact: Bret E. Friday    888-203-7267      
Principal Investigator: Bret E. Friday         
Unity Hospital Recruiting
Fridley, Minnesota, United States, 55432
Contact: Joseph W. Leach    952-993-1517    mmcorc@parknicollet.com   
Principal Investigator: Joseph W. Leach         
Hutchinson Area Health Care Suspended
Hutchinson, Minnesota, United States, 55350
Minnesota Oncology Hematology PA-Maplewood Recruiting
Maplewood, Minnesota, United States, 55109
Contact: Joseph W. Leach    952-993-1517    mmcorc@parknicollet.com   
Principal Investigator: Joseph W. Leach         
Saint John's Hospital - Healtheast Recruiting
Maplewood, Minnesota, United States, 55109
Contact: Joseph W. Leach    952-993-1517    mmcorc@parknicollet.com   
Principal Investigator: Joseph W. Leach         
Abbott-Northwestern Hospital Recruiting
Minneapolis, Minnesota, United States, 55407
Contact: Joseph W. Leach    952-993-1517    mmcorc@parknicollet.com   
Principal Investigator: Joseph W. Leach         
Hennepin County Medical Center Recruiting
Minneapolis, Minnesota, United States, 55415
Contact: Joseph W. Leach    952-993-1517    mmcorc@parknicollet.com   
Principal Investigator: Joseph W. Leach         
Health Partners Inc Recruiting
Minneapolis, Minnesota, United States, 55454
Contact: Joseph W. Leach    952-993-1517    mmcorc@parknicollet.com   
Principal Investigator: Joseph W. Leach         
North Memorial Medical Health Center Recruiting
Robbinsdale, Minnesota, United States, 55422
Contact: Joseph W. Leach    952-993-1517    mmcorc@parknicollet.com   
Principal Investigator: Joseph W. Leach         
Mayo Clinic Recruiting
Rochester, Minnesota, United States, 55905
Contact: Grzegorz S. Nowakowski    855-776-0015      
Principal Investigator: Grzegorz S. Nowakowski         
Coborn Cancer Center at Saint Cloud Hospital Recruiting
Saint Cloud, Minnesota, United States, 56303
Contact: Donald J. Jurgens    877-229-4907    coborncancercenter@centracare.com   
Principal Investigator: Donald J. Jurgens         
Metro Minnesota Community Oncology Research Consortium Terminated
Saint Louis Park, Minnesota, United States, 55416
Park Nicollet Clinic - Saint Louis Park Recruiting
Saint Louis Park, Minnesota, United States, 55416
Contact: Joseph W. Leach    952-993-1517    mmcorc@parknicollet.com   
Principal Investigator: Joseph W. Leach         
Regions Hospital Recruiting
Saint Paul, Minnesota, United States, 55101
Contact: Joseph W. Leach    952-993-1517    mmcorc@parknicollet.com   
Principal Investigator: Joseph W. Leach         
United Hospital Recruiting
Saint Paul, Minnesota, United States, 55102
Contact: Joseph W. Leach    952-993-1517    mmcorc@parknicollet.com   
Principal Investigator: Joseph W. Leach         
Saint Francis Regional Medical Center Recruiting
Shakopee, Minnesota, United States, 55379
Contact: Joseph W. Leach    952-993-1517    mmcorc@parknicollet.com   
Principal Investigator: Joseph W. Leach         
Lakeview Hospital Recruiting
Stillwater, Minnesota, United States, 55082
Contact: Joseph W. Leach    952-993-1517    mmcorc@parknicollet.com   
Principal Investigator: Joseph W. Leach         
Ridgeview Medical Center Recruiting
Waconia, Minnesota, United States, 55387
Contact: Joseph W. Leach    952-993-1517    mmcorc@parknicollet.com   
Principal Investigator: Joseph W. Leach         
Rice Memorial Hospital Recruiting
Willmar, Minnesota, United States, 56201
Contact: Joseph W. Leach    952-993-1517    mmcorc@parknicollet.com   
Principal Investigator: Joseph W. Leach         
Minnesota Oncology Hematology PA-Woodbury Recruiting
Woodbury, Minnesota, United States, 55125
Contact: Joseph W. Leach    952-993-1517    mmcorc@parknicollet.com   
Principal Investigator: Joseph W. Leach         
United States, Mississippi
University of Mississippi Medical Center Recruiting
Jackson, Mississippi, United States, 39216
Contact: Stephanie L. Elkins    601-815-6700      
Principal Investigator: Stephanie L. Elkins         
United States, Missouri
Central Care Cancer Center-Carrie J Babb Cancer Center Recruiting
Bolivar, Missouri, United States, 65613
Contact: Jay W. Carlson    800-821-7532      
Principal Investigator: Jay W. Carlson         
Saint Francis Medical Center Recruiting
Cape Girardeau, Missouri, United States, 63703
Contact: James L. Wade    217-876-4740    kcheek@dmhhs.org   
Principal Investigator: James L. Wade         
Southeast Cancer Center Recruiting
Cape Girardeau, Missouri, United States, 63703
Contact: James L. Wade    217-876-4740    kcheek@dmhhs.org   
Principal Investigator: James L. Wade         
Saint Luke's Hospital Recruiting
Chesterfield, Missouri, United States, 63017
Contact: Donald F. Busiek    314-205-6936      
Principal Investigator: Donald F. Busiek         
Capital Region Medical Center-Goldschmidt Cancer Center Recruiting
Jefferson City, Missouri, United States, 65109
Contact: James L. Wade    217-876-4740    kcheek@dmhhs.org   
Principal Investigator: James L. Wade         
Saint Luke's Hospital of Kansas City Recruiting
Kansas City, Missouri, United States, 64111
Contact: Rakesh Gaur    913-948-5588    aroland@kccop.org   
Principal Investigator: Rakesh Gaur         
Phelps County Regional Medical Center Suspended
Rolla, Missouri, United States, 65401
Saint John's Clinic-Rolla-Cancer and Hematology Recruiting
Rolla, Missouri, United States, 65401
Contact: Jay W. Carlson    800-821-7532      
Principal Investigator: Jay W. Carlson         
Saint Louis Cancer and Breast Institute-South City Suspended
Saint Louis, Missouri, United States, 63109
Missouri Baptist Medical Center Recruiting
Saint Louis, Missouri, United States, 63131
Contact: James L. Wade    217-876-4740    kcheek@dmhhs.org   
Principal Investigator: James L. Wade         
Mercy Hospital Saint Louis Suspended
Saint Louis, Missouri, United States, 63141
Mercy Hospital Springfield Recruiting
Springfield, Missouri, United States, 65804
Contact: Jay W. Carlson    800-821-7532      
Principal Investigator: Jay W. Carlson         
CoxHealth South Hospital Suspended
Springfield, Missouri, United States, 65807
United States, Montana
Billings Clinic Cancer Center Recruiting
Billings, Montana, United States, 59101
Contact: Benjamin T. Marchello    800-648-6274      
Principal Investigator: Benjamin T. Marchello         
Bozeman Deaconess Hospital Recruiting
Bozeman, Montana, United States, 59715
Contact: Benjamin T. Marchello    800-648-6274      
Principal Investigator: Benjamin T. Marchello         
Saint James Community Hospital and Cancer Treatment Center Suspended
Butte, Montana, United States, 59701
Benefis Healthcare- Sletten Cancer Institute Recruiting
Great Falls, Montana, United States, 59405
Contact: Benjamin T. Marchello    800-648-6274      
Principal Investigator: Benjamin T. Marchello         
Kalispell Regional Medical Center Recruiting
Kalispell, Montana, United States, 59901
Contact: Benjamin T. Marchello    800-648-6274      
Principal Investigator: Benjamin T. Marchello         
Saint Patrick Hospital - Community Hospital Suspended
Missoula, Montana, United States, 59802
Community Medical Hospital Recruiting
Missoula, Montana, United States, 59804
Contact: Benjamin T. Marchello    800-648-6274      
Principal Investigator: Benjamin T. Marchello         
United States, Nebraska
CHI Health Saint Francis Recruiting
Grand Island, Nebraska, United States, 68803
Contact: Mehmet S. Copur    800-998-2119      
Principal Investigator: Mehmet S. Copur         
CHI Health Good Samaritan Recruiting
Kearney, Nebraska, United States, 68847
Contact: Mehmet S. Copur    800-998-2119      
Principal Investigator: Mehmet S. Copur         
Nebraska Cancer Research Center Suspended
Lincoln, Nebraska, United States, 68510
University of Nebraska Medical Center Recruiting
Omaha, Nebraska, United States, 68198
Contact: Philip J. Bierman    402-559-6941    unmcrsa@unmc.edu   
Principal Investigator: Philip J. Bierman         
United States, Nevada
Cancer and Blood Specialists-Henderson Recruiting
Henderson, Nevada, United States, 89052
Contact: John A. Ellerton    702-384-0013      
Principal Investigator: John A. Ellerton         
Comprehensive Cancer Centers of Nevada - Henderson Recruiting
Henderson, Nevada, United States, 89052
Contact: John A. Ellerton    702-384-0013      
Principal Investigator: John A. Ellerton         
Las Vegas Cancer Center-Henderson Recruiting
Henderson, Nevada, United States, 89052
Contact: John A. Ellerton    702-384-0013      
Principal Investigator: John A. Ellerton         
21st Century Oncology - Henderson Recruiting
Henderson, Nevada, United States, 89074
Contact: John A. Ellerton    702-384-0013      
Principal Investigator: John A. Ellerton         
Comprehensive Cancer Centers of Nevada-Southeast Henderson Recruiting
Henderson, Nevada, United States, 89074
Contact: John A. Ellerton    702-384-0013      
Principal Investigator: John A. Ellerton         
University Medical Center of Southern Nevada Recruiting
Las Vegas, Nevada, United States, 89102
Contact: John A. Ellerton    702-384-0013      
Principal Investigator: John A. Ellerton         
Cancer and Blood Specialists-Shadow Recruiting
Las Vegas, Nevada, United States, 89106
Contact: John A. Ellerton    702-384-0013      
Principal Investigator: John A. Ellerton         
Nevada Cancer Research Foundation CCOP Recruiting
Las Vegas, Nevada, United States, 89106
Contact: John A. Ellerton    702-384-0013      
Principal Investigator: John A. Ellerton         
Radiation Oncology Centers of Nevada Central Recruiting
Las Vegas, Nevada, United States, 89106
Contact: John A. Ellerton    702-384-0013      
Principal Investigator: John A. Ellerton         
21st Century Oncology Recruiting
Las Vegas, Nevada, United States, 89109
Contact: John A. Ellerton    702-384-0013      
Principal Investigator: John A. Ellerton         
HealthCare Partners Medical Group Oncology/Hematology-Maryland Parkway Recruiting
Las Vegas, Nevada, United States, 89109
Contact: John A. Ellerton    702-384-0013      
Principal Investigator: John A. Ellerton         
HealthCare Partners Medical Group Oncology/Hematology-San Martin Recruiting
Las Vegas, Nevada, United States, 89113
Contact: John A. Ellerton    702-384-0013      
Principal Investigator: John A. Ellerton         
Radiation Oncology Centers of Nevada Southeast Recruiting
Las Vegas, Nevada, United States, 89119
Contact: John A. Ellerton    702-384-0013      
Principal Investigator: John A. Ellerton         
Cancer Therapy and Integrative Medicine Recruiting
Las Vegas, Nevada, United States, 89121
Contact: John A. Ellerton    702-384-0013      
Principal Investigator: John A. Ellerton         
Comprehensive Cancer Centers of Nevada - Northwest Recruiting
Las Vegas, Nevada, United States, 89128
Contact: John A. Ellerton    702-384-0013      
Principal Investigator: John A. Ellerton         
HealthCare Partners Medical Group Oncology/Hematology-Tenaya Recruiting
Las Vegas, Nevada, United States, 89128
Contact: John A. Ellerton    702-384-0013      
Principal Investigator: John A. Ellerton         
Comprehensive Cancer Centers of Nevada-Summerlin Recruiting
Las Vegas, Nevada, United States, 89144
Contact: John A. Ellerton    702-384-0013      
Principal Investigator: John A. Ellerton         
Las Vegas Cancer Center-Medical Center Recruiting
Las Vegas, Nevada, United States, 89148-2405
Contact: John A. Ellerton    702-384-0013      
Principal Investigator: John A. Ellerton         
21st Century Oncology - Fort Apache Recruiting
Las Vegas, Nevada, United States, 89148
Contact: John A. Ellerton    702-384-0013      
Principal Investigator: John A. Ellerton         
Cancer and Blood Specialists-Fort Apache Recruiting
Las Vegas, Nevada, United States, 89148
Contact: John A. Ellerton    702-384-0013      
Principal Investigator: John A. Ellerton         
Comprehensive Cancer Centers of Nevada Recruiting
Las Vegas, Nevada, United States, 89148
Contact: John A. Ellerton    702-384-0013      
Principal Investigator: John A. Ellerton         
HealthCare Partners Medical Group Oncology/Hematology-Centennial Hills Recruiting
Las Vegas, Nevada, United States, 89149
Contact: John A. Ellerton    702-384-0013      
Principal Investigator: John A. Ellerton         
Comprehensive Cancer Centers of Nevada - Central Valley Recruiting
Las Vegas, Nevada, United States, 89169
Contact: John A. Ellerton    702-384-0013      
Principal Investigator: John A. Ellerton         
21st Century Oncology - Vegas Tenaya Recruiting
Las Vegas, Nevada, United States, 89182
Contact: John A. Ellerton    702-384-0013      
Principal Investigator: John A. Ellerton         
United States, New Hampshire
New Hampshire Oncology Hematology PA-Concord Recruiting
Concord, New Hampshire, United States, 03301
Contact: Douglas J. Weckstein    603-224-2556      
Principal Investigator: Douglas J. Weckstein         
Wentworth-Douglass Hospital Recruiting
Dover, New Hampshire, United States, 03820
Contact: Henry L. Sonneborn    603-740-2150      
Principal Investigator: Henry L. Sonneborn         
New Hampshire Oncology Hematology PA-Hooksett Recruiting
Hooksett, New Hampshire, United States, 03106
Contact: Douglas J. Weckstein    603-224-2556      
Principal Investigator: Douglas J. Weckstein         
LRGHealthcare-Lakes Region General Hospital Suspended
Laconia, New Hampshire, United States, 03246
Dartmouth Hitchcock Medical Center Recruiting
Lebanon, New Hampshire, United States, 03756
Contact: Frederick Lansigan    800-639-6918    cancer.research.nurse@dartmouth.edu   
Principal Investigator: Frederick Lansigan         
United States, New Jersey
Cooper Hospital University Medical Center Active, not recruiting
Camden, New Jersey, United States, 08103
Englewood Hospital and Medical Center Recruiting
Englewood, New Jersey, United States, 07631
Contact: Francis A. Forte    201-894-3456      
Principal Investigator: Francis A. Forte         
Saint Barnabas Medical Center Suspended
Livingston, New Jersey, United States, 07039
Virtua Memorial Recruiting
Mount Holly, New Jersey, United States, 08060
Contact: James W. Lee    609-914-6762      
Principal Investigator: James W. Lee         
The Valley Hospital-Luckow Pavilion Recruiting
Paramus, New Jersey, United States, 07652
Contact: Jason Suh    201-634-5792      
Principal Investigator: Jason Suh         
Valley Hospital Recruiting
Ridgewood, New Jersey, United States, 07450
Contact: Jason Suh    201-634-5792      
Principal Investigator: Jason Suh         
Inspira Medical Center Vineland Recruiting
Vineland, New Jersey, United States, 08360
Contact: Ramakrishna R. Sudhindra    856-641-7933      
Principal Investigator: Ramakrishna R. Sudhindra         
Valley Health System-Hematology/Oncology Recruiting
Westwood, New Jersey, United States, 07675
Contact: Jason Suh    201-634-5792      
Principal Investigator: Jason Suh         
Inspira Medical Center Woodbury Recruiting
Woodbury, New Jersey, United States, 08096
Contact: Tami L. Bach    856-641-7933      
Principal Investigator: Tami L. Bach         
United States, New Mexico
University of New Mexico Cancer Center Suspended
Albuquerque, New Mexico, United States, 87102
Presbyterian Kaseman Hospital Suspended
Albuquerque, New Mexico, United States, 87110
Memorial Medical Center - Las Cruces Suspended
Las Cruces, New Mexico, United States, 88011
Christus Saint Vincent Regional Cancer Center Recruiting
Santa Fe, New Mexico, United States, 87505
Contact: Matthew Fero    505-925-0366    LByatt@nmcca.org   
Principal Investigator: Matthew Fero         
United States, New York
Montefiore Medical Center-Einstein Campus Recruiting
Bronx, New York, United States, 10461
Contact: Ramakrishna Battini    718-904-2730    aecc@aecom.yu.edu   
Principal Investigator: Ramakrishna Battini         
Montefiore Medical Center-Weiler Hospital Suspended
Bronx, New York, United States, 10461
Montefiore Medical Center - Moses Campus Recruiting
Bronx, New York, United States, 10467-2490
Contact: Ramakrishna Battini    718-904-2730    aecc@aecom.yu.edu   
Principal Investigator: Ramakrishna Battini         
Kings County Hospital Active, not recruiting
Brooklyn, New York, United States, 11203
State University of New York Downstate Medical Center Active, not recruiting
Brooklyn, New York, United States, 11203
Roswell Park Cancer Institute Suspended
Buffalo, New York, United States, 14263
Hematology Oncology Associates of Central New York-East Syracuse Active, not recruiting
East Syracuse, New York, United States, 13057
Laura and Isaac Perlmutter Cancer Center at NYU Langone Recruiting
New York, New York, United States, 10016
Contact: Catherine S. Diefenbach    212-263-4434    prmc.coordinator@nyumc.org   
Principal Investigator: Catherine S. Diefenbach         
Columbia University/Herbert Irving Cancer Center Suspended
New York, New York, United States, 10032
Champlain Valley Physicians Hospital Medical Center Recruiting
Plattsburgh, New York, United States, 12901
Contact: Jan E. Duus    518-561-2000      
Principal Investigator: Jan E. Duus         
University of Rochester Recruiting
Rochester, New York, United States, 14642
Contact: Jonathan W. Friedberg    585-275-5830      
Principal Investigator: Jonathan W. Friedberg         
State University of New York Upstate Medical University Suspended
Syracuse, New York, United States, 13210
United States, North Carolina
Randolph Hospital Suspended
Asheboro, North Carolina, United States, 27203
UNC Lineberger Comprehensive Cancer Center Recruiting
Chapel Hill, North Carolina, United States, 27599
Contact: Steven I. Park    877-668-0683    cancerclinicaltrials@med.unc.edu   
Principal Investigator: Steven I. Park         
Southeastern Medical Oncology Center-Clinton Recruiting
Clinton, North Carolina, United States, 28328
Contact: James N. Atkins    919-580-0000      
Principal Investigator: James N. Atkins         
Southeastern Medical Oncology Center-Goldsboro Recruiting
Goldsboro, North Carolina, United States, 27534
Contact: James N. Atkins    919-580-0000      
Principal Investigator: James N. Atkins         
Wayne Memorial Hospital Recruiting
Goldsboro, North Carolina, United States, 27534
Contact: James N. Atkins    919-580-0000      
Principal Investigator: James N. Atkins         
Cone Health Cancer Center Suspended
Greensboro, North Carolina, United States, 27403
Hendersonville Hematology and Oncology at Pardee Recruiting
Hendersonville, North Carolina, United States, 28791
Contact: James E. Radford    828-696-4716      
Principal Investigator: James E. Radford         
Margaret R Pardee Memorial Hospital Recruiting
Hendersonville, North Carolina, United States, 28791
Contact: James E. Radford    828-696-4716      
Principal Investigator: James E. Radford         
Southeastern Medical Oncology Center-Jacksonville Recruiting
Jacksonville, North Carolina, United States, 28546
Contact: James N. Atkins    919-580-0000      
Principal Investigator: James N. Atkins         
Kinston Medical Specialists PA Recruiting
Kinston, North Carolina, United States, 28501
Contact: Peter R. Watson    252-559-2200      
Principal Investigator: Peter R. Watson         
Annie Penn Memorial Hospital Suspended
Reidsville, North Carolina, United States, 27320
Iredell Memorial Hospital Active, not recruiting
Statesville, North Carolina, United States, 28677
Marion L Shepard Cancer Center at Vidant Beaufort Hospital Recruiting
Washington, North Carolina, United States, 27889
Contact: John J. Inzerillo    252-975-4308      
Principal Investigator: John J. Inzerillo         
Southeastern Medical Oncology Center-Wilson Recruiting
Wilson, North Carolina, United States, 27893
Contact: James N. Atkins    919-580-0000      
Principal Investigator: James N. Atkins         
Wake Forest University Health Sciences Recruiting
Winston-Salem, North Carolina, United States, 27157
Contact: Zanetta S. Lamar    336-713-6771      
Principal Investigator: Zanetta S. Lamar         
United States, North Dakota
Sanford Bismarck Medical Center Recruiting
Bismarck, North Dakota, United States, 58501
Contact: Preston D. Steen    701-234-6161      
Principal Investigator: Preston D. Steen         
Roger Maris Cancer Center Recruiting
Fargo, North Dakota, United States, 58122
Contact: Preston D. Steen    701-234-6161      
Principal Investigator: Preston D. Steen         
Sanford Clinic North-Fargo Recruiting
Fargo, North Dakota, United States, 58122
Contact: Preston D. Steen    701-234-6161      
Principal Investigator: Preston D. Steen         
Sanford Medical Center-Fargo Recruiting
Fargo, North Dakota, United States, 58122
Contact: Preston D. Steen    701-234-6161      
Principal Investigator: Preston D. Steen         
United States, Ohio
Summa Akron City Hospital/Cooper Cancer Center Recruiting
Akron, Ohio, United States, 44304
Contact: Jennifer E. Payne    330-375-6101      
Principal Investigator: Jennifer E. Payne         
Akron General Medical Center Recruiting
Akron, Ohio, United States, 44307
Contact: Esther H. Rehmus    330-344-6348      
Principal Investigator: Esther H. Rehmus         
Summa Barberton Hospital Recruiting
Barberton, Ohio, United States, 44203
Contact: Jennifer E. Payne    330-375-6101      
Principal Investigator: Jennifer E. Payne         
Mercy Medical Center Recruiting
Canton, Ohio, United States, 44708
Contact: Mitchell Haut    888-293-4673      
Principal Investigator: Mitchell Haut         
Geaugra Hospital Suspended
Chardon, Ohio, United States, 44024
Good Samaritan Hospital - Cincinnati Recruiting
Cincinnati, Ohio, United States, 45220
Contact: Mehmet S. Copur    800-998-2119      
Principal Investigator: Mehmet S. Copur         
TriHealth Cancer Institute-Westside Recruiting
Cincinnati, Ohio, United States, 45247
Contact: Mehmet S. Copur    800-998-2119      
Principal Investigator: Mehmet S. Copur         
TriHealth Cancer Institute-Anderson Recruiting
Cincinnati, Ohio, United States, 45255
Contact: Mehmet S. Copur    800-998-2119      
Principal Investigator: Mehmet S. Copur         
University of Cincinnati Recruiting
Cincinnati, Ohio, United States, 45267
Contact: Stephen C. Medlin    513-558-4553    uchealthnews@uc.edu   
Principal Investigator: Stephen C. Medlin         
Case Western Reserve University Suspended
Cleveland, Ohio, United States, 44106
MetroHealth Medical Center Recruiting
Cleveland, Ohio, United States, 44109
Contact: Bruce J. Averbook    216-778-8526    kbauchens@metrohealth.org   
Principal Investigator: Bruce J. Averbook         
Ohio State University Comprehensive Cancer Center Recruiting
Columbus, Ohio, United States, 43210
Contact: Kami J. Maddocks    800-293-5066    Jamesline@osumc.edu   
Principal Investigator: Kami J. Maddocks         
Columbus Oncology and Hematology Associates Inc Recruiting
Columbus, Ohio, United States, 43214
Contact: John P. Kuebler    614-488-2745    sheree@columbusccop.org   
Principal Investigator: John P. Kuebler         
Riverside Methodist Hospital Recruiting
Columbus, Ohio, United States, 43214
Contact: John P. Kuebler    614-488-2745    sheree@columbusccop.org   
Principal Investigator: John P. Kuebler         
Columbus NCI Community Oncology Research Program Terminated
Columbus, Ohio, United States, 43215
The Mark H Zangmeister Center Recruiting
Columbus, Ohio, United States, 43219
Contact: John P. Kuebler    614-488-2745    sheree@columbusccop.org   
Principal Investigator: John P. Kuebler         
Mount Carmel Health Center West Recruiting
Columbus, Ohio, United States, 43222
Contact: John P. Kuebler    614-488-2745    sheree@columbusccop.org   
Principal Investigator: John P. Kuebler         
Good Samaritan Hospital - Dayton Suspended
Dayton, Ohio, United States, 45406
Miami Valley Hospital Suspended
Dayton, Ohio, United States, 45409
Samaritan North Health Center Suspended
Dayton, Ohio, United States, 45415
Mercy Cancer Center-Elyria Suspended
Elyria, Ohio, United States, 44035
Blanchard Valley Hospital Suspended
Findlay, Ohio, United States, 45840
Saint Rita's Medical Center Recruiting
Lima, Ohio, United States, 45801
Contact: Chris A. Rhoades    419-226-9617      
Principal Investigator: Chris A. Rhoades         
Marietta Memorial Hospital Recruiting
Marietta, Ohio, United States, 45750
Contact: John P. Kuebler    614-488-2745    sheree@columbusccop.org   
Principal Investigator: John P. Kuebler         
Toledo Clinic Cancer Centers-Maumee Recruiting
Maumee, Ohio, United States, 43537
Contact: Rex B. Mowat    800-444-3561      
Principal Investigator: Rex B. Mowat         
Ireland Cancer Center Landerbrook Health Center Suspended
Mayfield Heights, Ohio, United States, 44124
Lake University Ireland Cancer Center Suspended
Mentor, Ohio, United States, 44060
Licking Memorial Hospital Recruiting
Newark, Ohio, United States, 43055
Contact: John P. Kuebler    614-488-2745    sheree@columbusccop.org   
Principal Investigator: John P. Kuebler         
Ireland Cancer Center at Firelands Regional Medical Center Suspended
Sandusky, Ohio, United States, 44870
Springfield Regional Cancer Center Suspended
Springfield, Ohio, United States, 45504
Springfield Regional Medical Center Suspended
Springfield, Ohio, United States, 45505
Flower Hospital Recruiting
Sylvania, Ohio, United States, 43560
Contact: Jeffrey H. Muler    419-824-1842      
Principal Investigator: Jeffrey H. Muler         
University of Toledo Active, not recruiting
Toledo, Ohio, United States, 43614
Toledo Clinic Cancer Centers-Toledo Recruiting
Toledo, Ohio, United States, 43623
Contact: Rex B. Mowat    800-444-3561      
Principal Investigator: Rex B. Mowat         
Saint Ann's Hospital Recruiting
Westerville, Ohio, United States, 43081
Contact: John P. Kuebler    614-488-2745    sheree@columbusccop.org   
Principal Investigator: John P. Kuebler         
UH-Seidman Cancer Center at Saint John Medical Center Suspended
Westlake, Ohio, United States, 44145
United States, Oklahoma
University of Oklahoma Health Sciences Center Recruiting
Oklahoma City, Oklahoma, United States, 73104
Contact: Mohamad Cherry    405-271-8777    ou-clinical-trials@ouhsc.edu   
Principal Investigator: Mohamad Cherry         
Oklahoma Cancer Specialists and Research Institute-Tulsa Recruiting
Tulsa, Oklahoma, United States, 74146
Contact: Mohamad Cherry    405-271-8777    ou-clinical-trials@ouhsc.edu   
Principal Investigator: Mohamad Cherry         
United States, Oregon
Clackamas Radiation Oncology Center Recruiting
Clackamas, Oregon, United States, 97015
Contact: Keith S. Lanier    503-215-2614    CanRsrchStudies@providence.org   
Principal Investigator: Keith S. Lanier         
Providence Oncology and Hematology Care Southeast Recruiting
Clackamas, Oregon, United States, 97015
Contact: Keith S. Lanier    503-215-2614    CanRsrchStudies@providence.org   
Principal Investigator: Keith S. Lanier         
Bay Area Hospital Recruiting
Coos Bay, Oregon, United States, 97420
Contact: Keith S. Lanier    503-215-2614    CanRsrchStudies@providence.org   
Principal Investigator: Keith S. Lanier         
Providence Newberg Medical Center Recruiting
Newberg, Oregon, United States, 97132
Contact: Keith S. Lanier    503-215-2614    CanRsrchStudies@providence.org   
Principal Investigator: Keith S. Lanier         
Providence Willamette Falls Medical Center Recruiting
Oregon City, Oregon, United States, 97045
Contact: Keith S. Lanier    503-215-2614    CanRsrchStudies@providence.org   
Principal Investigator: Keith S. Lanier         
Providence Portland Medical Center Recruiting
Portland, Oregon, United States, 97213
Contact: Keith S. Lanier    503-215-2614    CanRsrchStudies@providence.org   
Principal Investigator: Keith S. Lanier         
Providence Saint Vincent Medical Center Recruiting
Portland, Oregon, United States, 97225
Contact: Keith S. Lanier    503-215-2614    CanRsrchStudies@providence.org   
Principal Investigator: Keith S. Lanier         
United States, Pennsylvania
Lehigh Valley Hospital-Cedar Crest Recruiting
Allentown, Pennsylvania, United States, 18103
Contact: Eliot L. Friedman    610-402-2273      
Principal Investigator: Eliot L. Friedman         
Saint Luke's University Hospital-Bethlehem Campus Recruiting
Bethlehem, Pennsylvania, United States, 18015
Contact: Neil D. Belman    610-954-3582    infolink@slhn.org   
Principal Investigator: Neil D. Belman         
Bryn Mawr Hospital Active, not recruiting
Bryn Mawr, Pennsylvania, United States, 19010
Geisinger Medical Center Recruiting
Danville, Pennsylvania, United States, 17822
Contact: Joseph J. Vadakara    570-271-5251      
Principal Investigator: Joseph J. Vadakara         
Doylestown Hospital Suspended
Doylestown, Pennsylvania, United States, 18901
Delaware County Memorial Hospital Suspended
Drexel Hill, Pennsylvania, United States, 19026
Ephrata Cancer Center Recruiting
Ephrata, Pennsylvania, United States, 17522
Contact: Amir Tabatabai    877-441-7957      
Principal Investigator: Amir Tabatabai         
Ephrata Community Hospital Suspended
Ephrata, Pennsylvania, United States, 17522
Adams Cancer Center Recruiting
Gettysburg, Pennsylvania, United States, 17325
Contact: Amir Tabatabai    877-441-7957      
Principal Investigator: Amir Tabatabai         
Cherry Tree Cancer Center Recruiting
Hanover, Pennsylvania, United States, 17331
Contact: Amir Tabatabai    877-441-7957      
Principal Investigator: Amir Tabatabai         
Geisinger Medical Center-Cancer Center Hazleton Recruiting
Hazleton, Pennsylvania, United States, 18201
Contact: Joseph J. Vadakara    570-271-5251      
Principal Investigator: Joseph J. Vadakara         
Penn State Milton S Hershey Medical Center Recruiting
Hershey, Pennsylvania, United States, 17033-0850
Contact: Witold B. Rybka    717-531-3779    CTO@hmc.psu.edu   
Principal Investigator: Witold B. Rybka         
Geisinger Medical Oncology-Lewisburg Recruiting
Lewisburg, Pennsylvania, United States, 17837
Contact: Joseph J. Vadakara    570-271-5251      
Principal Investigator: Joseph J. Vadakara         
Paoli Memorial Hospital Active, not recruiting
Paoli, Pennsylvania, United States, 19301
University of Pennsylvania/Abramson Cancer Center Suspended
Philadelphia, Pennsylvania, United States, 19104
Thomas Jefferson University Hospital Recruiting
Philadelphia, Pennsylvania, United States, 19107
Contact: Joanne E. Filicko-O'Hara    215-955-6084      
Principal Investigator: Joanne E. Filicko-O'Hara         
Fox Chase Cancer Center Suspended
Philadelphia, Pennsylvania, United States, 19111
Temple University Hospital Active, not recruiting
Philadelphia, Pennsylvania, United States, 19140
Pottstown Memorial Medical Center Recruiting
Pottstown, Pennsylvania, United States, 19464
Contact: Wei (. Song    610-327-7544      
Principal Investigator: Wei (. Song         
Geisinger Medical Oncology-Pottsville Recruiting
Pottsville, Pennsylvania, United States, 17901
Contact: Joseph J. Vadakara    570-271-5251      
Principal Investigator: Joseph J. Vadakara         
Hematology and Oncology Associates of North East Pennsylvania Recruiting
Scranton, Pennsylvania, United States, 18508
Contact: Joanne E. Filicko-O'Hara    215-955-6084      
Principal Investigator: Joanne E. Filicko-O'Hara         
Geisinger Medical Oncology-Selinsgrove Recruiting
Selinsgrove, Pennsylvania, United States, 17870
Contact: Joseph J. Vadakara    570-271-5251      
Principal Investigator: Joseph J. Vadakara         
Grand View Hospital Withdrawn
Sellersville, Pennsylvania, United States, 18960
Mount Nittany Medical Center Recruiting
State College, Pennsylvania, United States, 16803
Contact: Witold B. Rybka    717-531-3779    CTO@hmc.psu.edu   
Principal Investigator: Witold B. Rybka         
Chester County Hospital Suspended
West Chester, Pennsylvania, United States, 19380
Reading Hospital Recruiting
West Reading, Pennsylvania, United States, 19611
Contact: Terrence P. Cescon    610-988-9323      
Principal Investigator: Terrence P. Cescon         
Geisinger Wyoming Valley/Henry Cancer Center Recruiting
Wilkes-Barre, Pennsylvania, United States, 18711
Contact: Joseph J. Vadakara    570-271-5251      
Principal Investigator: Joseph J. Vadakara         
Lankenau Medical Center Active, not recruiting
Wynnewood, Pennsylvania, United States, 19096
WellSpan Health-York Hospital Recruiting
York, Pennsylvania, United States, 17403
Contact: Amir Tabatabai    877-441-7957      
Principal Investigator: Amir Tabatabai         
United States, South Carolina
Greenville Health System Cancer Institute-Easley Recruiting
Easley, South Carolina, United States, 29640
Contact: Jeffrey K. Giguere    864-241-6251      
Principal Investigator: Jeffrey K. Giguere         
Greenville Health System Cancer Institute-Andrews Suspended
Greenville, South Carolina, United States, 29605
Greenville Health System Cancer Institute-Butternut Recruiting
Greenville, South Carolina, United States, 29605
Contact: Jeffrey K. Giguere    864-241-6251      
Principal Investigator: Jeffrey K. Giguere         
Greenville Health System Cancer Institute-Faris Recruiting
Greenville, South Carolina, United States, 29605
Contact: Jeffrey K. Giguere    864-241-6251      
Principal Investigator: Jeffrey K. Giguere         
Greenville Memorial Hospital Recruiting
Greenville, South Carolina, United States, 29605
Contact: Jeffrey K. Giguere    864-241-6251      
Principal Investigator: Jeffrey K. Giguere         
Greenville Health System Cancer Institute-Eastside Recruiting
Greenville, South Carolina, United States, 29615
Contact: Jeffrey K. Giguere    864-241-6251      
Principal Investigator: Jeffrey K. Giguere         
Greenville Health System Cancer Institute-Greer Recruiting
Greer, South Carolina, United States, 29650
Contact: Jeffrey K. Giguere    864-241-6251      
Principal Investigator: Jeffrey K. Giguere         
Greenville Health System Cancer Institute-Seneca Recruiting
Seneca, South Carolina, United States, 29672
Contact: Jeffrey K. Giguere    864-241-6251      
Principal Investigator: Jeffrey K. Giguere         
Greenville Health System Cancer Institute-Spartanburg Recruiting
Spartanburg, South Carolina, United States, 29307
Contact: Jeffrey K. Giguere    864-241-6251      
Principal Investigator: Jeffrey K. Giguere         
United States, South Dakota
Rapid City Regional Hospital Recruiting
Rapid City, South Dakota, United States, 57701
Contact: Joshua C. Lukenbill    605-716-3982    research@rcrh.org   
Principal Investigator: Joshua C. Lukenbill         
Sanford Cancer Center-Oncology Clinic Recruiting
Sioux Falls, South Dakota, United States, 57104
Contact: Preston D. Steen    701-234-6161      
Principal Investigator: Preston D. Steen         
Avera Cancer Institute Recruiting
Sioux Falls, South Dakota, United States, 57105
Contact: Amy K. Krie    888-634-7268    oncregulatory@avera.org   
Principal Investigator: Amy K. Krie         
Sanford USD Medical Center - Sioux Falls Recruiting
Sioux Falls, South Dakota, United States, 57117-5134
Contact: Preston D. Steen    701-234-6161      
Principal Investigator: Preston D. Steen         
United States, Tennessee
Vanderbilt University/Ingram Cancer Center Recruiting
Nashville, Tennessee, United States, 37232
Contact: Nishitha Reddy    800-811-8480      
Principal Investigator: Nishitha Reddy         
United States, Texas
University Medical Center Brackenridge Recruiting
Austin, Texas, United States, 78701
Contact: Alka Mallik    512-324-7991      
Principal Investigator: Alka Mallik         
Parkland Memorial Hospital Recruiting
Dallas, Texas, United States, 75235
Contact: Madhuri Vusirikala    214-648-7097      
Principal Investigator: Madhuri Vusirikala         
UT Southwestern/Simmons Cancer Center-Dallas Recruiting
Dallas, Texas, United States, 75390
Contact: Madhuri Vusirikala    214-648-7097      
Principal Investigator: Madhuri Vusirikala         
Brooke Army Medical Center Suspended
Fort Sam Houston, Texas, United States, 78234
Covenant Medical Center-Lakeside Suspended
Lubbock, Texas, United States, 79410
Texas Tech University Health Sciences Center Recruiting
Lubbock, Texas, United States, 79430
Contact: Nicholas C. D'Cunha    315-464-5476      
Principal Investigator: Nicholas C. D'Cunha         
University of Texas Health Science Center at San Antonio Suspended
San Antonio, Texas, United States, 78229
United States, Utah
Huntsman Cancer Institute/University of Utah Recruiting
Salt Lake City, Utah, United States, 84112
Contact: Deborah M. Stephens    801-581-4477    clinical.trials@hci.utah.edu   
Principal Investigator: Deborah M. Stephens         
United States, Virginia
University of Virginia Cancer Center Recruiting
Charlottesville, Virginia, United States, 22908
Contact: Michael E. Williams    434-243-6322    JME3D@hscmail.mcc.virginia.edu   
Principal Investigator: Michael E. Williams         
Augusta Health Cancer Center Recruiting
Fishersville, Virginia, United States, 22939
Contact: Zuhair Ghanem    540-245-7106      
Principal Investigator: Zuhair Ghanem         
Memorial Hospital Of Martinsville Recruiting
Martinsville, Virginia, United States, 24115
Contact: Sreedhar Katragadda    276-666-7827      
Principal Investigator: Sreedhar Katragadda         
United States, Washington
Swedish Medical Center-Edmonds Recruiting
Edmonds, Washington, United States, 98026
Contact: Keith S. Lanier    503-215-2614    CanRsrchStudies@providence.org   
Principal Investigator: Keith S. Lanier         
PeaceHealth Saint John Medical Center Recruiting
Longview, Washington, United States, 98632
Contact: Keith S. Lanier    503-215-2614    CanRsrchStudies@providence.org   
Principal Investigator: Keith S. Lanier         
Swedish Medical Center-Ballard Campus Recruiting
Seattle, Washington, United States, 98107
Contact: Keith S. Lanier    503-215-2614    CanRsrchStudies@providence.org   
Principal Investigator: Keith S. Lanier         
Swedish Medical Center-First Hill Recruiting
Seattle, Washington, United States, 98122-4307
Contact: Keith S. Lanier    503-215-2614    CanRsrchStudies@providence.org   
Principal Investigator: Keith S. Lanier         
PeaceHealth Southwest Medical Center Recruiting
Vancouver, Washington, United States, 98664
Contact: Keith S. Lanier    503-215-2614    CanRsrchStudies@providence.org   
Principal Investigator: Keith S. Lanier         
United States, West Virginia
West Virginia University Charleston Suspended
Charleston, West Virginia, United States, 25304
United States, Wisconsin
Langlade Hospital and Cancer Center Recruiting
Antigo, Wisconsin, United States, 54409
Contact: Hamied R. Rezazadeh    877-405-6866      
Principal Investigator: Hamied R. Rezazadeh         
Fox Valley Hematology and Oncology SC-Appleton Recruiting
Appleton, Wisconsin, United States, 54913
Contact: William A. Conkright    920-749-1171      
Principal Investigator: William A. Conkright         
Aurora Cancer Care-Burlington Recruiting
Burlington, Wisconsin, United States, 53105
Contact: Rubina Qamar    888-709-2080      
Principal Investigator: Rubina Qamar         
Marshfield Clinic Cancer Center at Sacred Heart Recruiting
Eau Claire, Wisconsin, United States, 54701
Contact: Ali W. Bseiso    715-389-4457      
Principal Investigator: Ali W. Bseiso         
Sacred Heart Hospital Recruiting
Eau Claire, Wisconsin, United States, 54701
Contact: Ali W. Bseiso    715-389-4457      
Principal Investigator: Ali W. Bseiso         
Aurora Cancer Care-Southern Lakes Recruiting
Elkhorn, Wisconsin, United States, 53121
Contact: Rubina Qamar    888-709-2080      
Principal Investigator: Rubina Qamar         
Aurora Health Care Germantown Health Center Recruiting
Germantown, Wisconsin, United States, 53022
Contact: Rubina Qamar    888-709-2080      
Principal Investigator: Rubina Qamar         
Aurora Cancer Care-Grafton Recruiting
Grafton, Wisconsin, United States, 53024
Contact: Rubina Qamar    888-709-2080      
Principal Investigator: Rubina Qamar         
Green Bay Oncology at Saint Vincent Hospital Recruiting
Green Bay, Wisconsin, United States, 54301-3526
Contact: Brian L. Burnette    800-432-6049      
Principal Investigator: Brian L. Burnette         
Bellin Memorial Hospital Active, not recruiting
Green Bay, Wisconsin, United States, 54301
Saint Vincent Hospital Recruiting
Green Bay, Wisconsin, United States, 54301
Contact: Brian L. Burnette    800-432-6049      
Principal Investigator: Brian L. Burnette         
Green Bay Oncology Limited at Saint Mary's Hospital Recruiting
Green Bay, Wisconsin, United States, 54303
Contact: Brian L. Burnette    800-432-6049      
Principal Investigator: Brian L. Burnette         
Saint Mary's Hospital Recruiting
Green Bay, Wisconsin, United States, 54303
Contact: Brian L. Burnette    800-432-6049      
Principal Investigator: Brian L. Burnette         
Aurora BayCare Medical Center Recruiting
Green Bay, Wisconsin, United States, 54311
Contact: Rubina Qamar    888-709-2080      
Principal Investigator: Rubina Qamar         
UW Cancer Center Johnson Creek Suspended
Johnson Creek, Wisconsin, United States, 53038
Aurora Cancer Care-Kenosha South Active, not recruiting
Kenosha, Wisconsin, United States, 53142
Gundersen Lutheran Medical Center Recruiting
La Crosse, Wisconsin, United States, 54601
Contact: Kurt Oettel    608-775-2385    cancerctr@gundersenhealth.org   
Principal Investigator: Kurt Oettel         
Dean Hematology and Oncology Clinic Recruiting
Madison, Wisconsin, United States, 53717
Contact: Amit Sanyal    608-410-2700      
Principal Investigator: Amit Sanyal         
University of Wisconsin Hospital and Clinics Recruiting
Madison, Wisconsin, United States, 53792
Contact: Vaishalee P. Kenkre    877-405-6866      
Principal Investigator: Vaishalee P. Kenkre         
Holy Family Memorial Hospital Recruiting
Manitowoc, Wisconsin, United States, 54221
Contact: Brian L. Burnette    800-432-6049      
Principal Investigator: Brian L. Burnette         
Bay Area Medical Center Suspended
Marinette, Wisconsin, United States, 54143
Vince Lombardi Cancer Clinic-Marinette Recruiting
Marinette, Wisconsin, United States, 54143
Contact: Rubina Qamar    888-709-2080      
Principal Investigator: Rubina Qamar         
Marshfield Clinic Recruiting
Marshfield, Wisconsin, United States, 54449
Contact: Ali W. Bseiso    715-389-4457      
Principal Investigator: Ali W. Bseiso         
Saint Joseph's Hospital Recruiting
Marshfield, Wisconsin, United States, 54449
Contact: Ali W. Bseiso    715-389-4457      
Principal Investigator: Ali W. Bseiso         
Aurora Cancer Care-Milwaukee Recruiting
Milwaukee, Wisconsin, United States, 53209
Contact: Rubina Qamar    888-709-2080      
Principal Investigator: Rubina Qamar         
Aurora Cancer Care-Milwaukee South Recruiting
Milwaukee, Wisconsin, United States, 53215
Contact: Rubina Qamar    888-709-2080      
Principal Investigator: Rubina Qamar         
Aurora Saint Luke's Medical Center Recruiting
Milwaukee, Wisconsin, United States, 53215
Contact: Rubina Qamar    888-709-2080      
Principal Investigator: Rubina Qamar         
Froedtert and the Medical College of Wisconsin Recruiting
Milwaukee, Wisconsin, United States, 53226
Contact: Timothy S. Fenske    414-805-4380      
Principal Investigator: Timothy S. Fenske         
Aurora Sinai Medical Center Recruiting
Milwaukee, Wisconsin, United States, 53233
Contact: Rubina Qamar    888-709-2080      
Principal Investigator: Rubina Qamar         
Marshfield Clinic-Minocqua Center Recruiting
Minocqua, Wisconsin, United States, 54548
Contact: Ali W. Bseiso    715-389-4457      
Principal Investigator: Ali W. Bseiso         
Cancer Center of Western Wisconsin Recruiting
New Richmond, Wisconsin, United States, 54017
Contact: Joseph W. Leach    952-993-1517    mmcorc@parknicollet.com   
Principal Investigator: Joseph W. Leach         
Oconomowoc Memorial Hospital-ProHealth Care Inc Recruiting
Oconomowoc, Wisconsin, United States, 53066
Contact: Timothy R. Wassenaar    262-928-5539    Chanda.miller@phci.org   
Principal Investigator: Timothy R. Wassenaar         
Green Bay Oncology - Oconto Falls Recruiting
Oconto Falls, Wisconsin, United States, 54154
Contact: Brian L. Burnette    800-432-6049      
Principal Investigator: Brian L. Burnette         
Vince Lombardi Cancer Clinic - Oshkosh Recruiting
Oshkosh, Wisconsin, United States, 54904
Contact: Rubina Qamar    888-709-2080      
Principal Investigator: Rubina Qamar         
Aurora Cancer Care-Racine Active, not recruiting
Racine, Wisconsin, United States, 53406
Marshfield Clinic at James Beck Cancer Center Suspended
Rhinelander, Wisconsin, United States, 54501
Saint Mary's Hospital Suspended
Rhinelander, Wisconsin, United States, 54501
Lakeview Medical Center-Marshfield Clinic Recruiting
Rice Lake, Wisconsin, United States, 54868
Contact: Ali W. Bseiso    715-389-4457      
Principal Investigator: Ali W. Bseiso         
Marshfield Clinic-Rice Lake Center Recruiting
Rice Lake, Wisconsin, United States, 54868
Contact: Ali W. Bseiso    715-389-4457      
Principal Investigator: Ali W. Bseiso         
Vince Lombardi Cancer Clinic-Sheboygan Recruiting
Sheboygan, Wisconsin, United States, 53081
Contact: Rubina Qamar    888-709-2080      
Principal Investigator: Rubina Qamar         
Marshfield Clinic Cancer Care at Saint Michael's Hospital Recruiting
Stevens Point, Wisconsin, United States, 54481
Contact: Ali W. Bseiso    715-389-4457      
Principal Investigator: Ali W. Bseiso         
Saint Michael's Hospital Recruiting
Stevens Point, Wisconsin, United States, 54481
Contact: Ali W. Bseiso    715-389-4457      
Principal Investigator: Ali W. Bseiso         
Green Bay Oncology - Sturgeon Bay Recruiting
Sturgeon Bay, Wisconsin, United States, 54235
Contact: Brian L. Burnette    800-432-6049      
Principal Investigator: Brian L. Burnette         
Aurora Medical Center in Summit Recruiting
Summit, Wisconsin, United States, 53066
Contact: Rubina Qamar    888-709-2080      
Principal Investigator: Rubina Qamar         
Vince Lombardi Cancer Clinic Recruiting
Two Rivers, Wisconsin, United States, 54241
Contact: Rubina Qamar    888-709-2080      
Principal Investigator: Rubina Qamar         
Aurora Cancer Care-Waukesha Suspended
Waukesha, Wisconsin, United States, 53188
UW Cancer Center at ProHealth Care Recruiting
Waukesha, Wisconsin, United States, 53188
Contact: Timothy R. Wassenaar    262-928-5539    Chanda.miller@phci.org   
Principal Investigator: Timothy R. Wassenaar         
Waukesha Memorial Hospital Recruiting
Waukesha, Wisconsin, United States, 53188
Contact: Timothy R. Wassenaar    262-928-5539    Chanda.miller@phci.org   
Principal Investigator: Timothy R. Wassenaar         
Aspirus Regional Cancer Center Recruiting
Wausau, Wisconsin, United States, 54401
Contact: Hamied R. Rezazadeh    877-405-6866      
Principal Investigator: Hamied R. Rezazadeh         
Marshfield Clinic-Wausau Center Recruiting
Wausau, Wisconsin, United States, 54401
Contact: Ali W. Bseiso    715-389-4457      
Principal Investigator: Ali W. Bseiso         
Aurora Cancer Care-Milwaukee West Recruiting
Wauwatosa, Wisconsin, United States, 53226
Contact: Rubina Qamar    888-709-2080      
Principal Investigator: Rubina Qamar         
Aurora West Allis Medical Center Recruiting
West Allis, Wisconsin, United States, 53227
Contact: Rubina Qamar    888-709-2080      
Principal Investigator: Rubina Qamar         
Diagnostic and Treatment Center Recruiting
Weston, Wisconsin, United States, 54476
Contact: Ali W. Bseiso    715-389-4457      
Principal Investigator: Ali W. Bseiso         
Marshfield Clinic - Weston Center Recruiting
Weston, Wisconsin, United States, 54476
Contact: Ali W. Bseiso    715-389-4457      
Principal Investigator: Ali W. Bseiso         
Aspirus UW Cancer Center Recruiting
Wisconsin Rapids, Wisconsin, United States, 54494
Contact: Ronnie J. Kirschling    877-405-6866      
Principal Investigator: Ronnie J. Kirschling         
Marshfield Clinic - Wisconsin Rapids Center Recruiting
Wisconsin Rapids, Wisconsin, United States, 54494
Contact: Ali W. Bseiso    715-389-4457      
Principal Investigator: Ali W. Bseiso         
Sponsors and Collaborators
National Cancer Institute (NCI)
Investigators
Principal Investigator: Grzegorz Nowakowski ECOG-ACRIN Cancer Research Group
  More Information

Responsible Party: National Cancer Institute (NCI)
ClinicalTrials.gov Identifier: NCT01856192     History of Changes
Other Study ID Numbers: NCI-2013-00959  NCI-2013-00959  ECOG-E1412  E1412  E1412  U10CA180820  U10CA021115 
Study First Received: May 14, 2013
Last Updated: December 1, 2016
Health Authority: United States: Food and Drug Administration

Additional relevant MeSH terms:
Lymphoma
Lymphoma, B-Cell
Lymphoma, Large B-Cell, Diffuse
Neoplasms by Histologic Type
Neoplasms
Lymphoproliferative Disorders
Lymphatic Diseases
Immunoproliferative Disorders
Immune System Diseases
Lymphoma, Non-Hodgkin
Doxorubicin
Liposomal doxorubicin
Lenalidomide
Prednisone
Thalidomide
Cyclophosphamide
Rituximab
Vincristine
Cortisone acetate
Cortisone
Antibodies
Immunoglobulins
Antibodies, Monoclonal
Antibiotics, Antineoplastic
Antineoplastic Agents
Topoisomerase II Inhibitors
Topoisomerase Inhibitors
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Anti-Inflammatory Agents

ClinicalTrials.gov processed this record on December 02, 2016